
<!DOCTYPE html>
<html lang="en"     class="pb-page"  data-request-id="6a4781de-1d14-4a18-bd55-7c06a4d2bf55"  
><head data-pb-dropzone="head"><meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pbContext" content=";article:article:doi\:10.1002/ijc.27863;page:string:Article/Chapter View;ctype:string:Journal Content;website:website:pericles;journal:journal:10970215;issue:issue:doi\:10.1002/ijc.v132.8;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text;requestedJournal:journal:10970215"/>

<script type="text/javascript">var $DoubleClickZone = "ij-cancer_ijc";var $DoubleClickSite =  "wly.onco.radthr_000091";</script><script id="analyticDigitalData">digitalData = {"site":{"ip":"216.165.249.165","environment":"LIVE","website":"onlinelibrary.wiley.com","websiteCode":"pericles","serverDate":"2022-03-06"},"identities":[{"type":"SmartGroupUser","uuid":"b238ab85-6bb4-49e4-84ca-a0d9f3ee5a35"},{"type":"SmartGroupUser","uuid":"eabce89b-65c2-4a09-ab7c-bd2b3fea2f10"},{"type":"RegionUser","uuid":"3c5060a1-6620-438f-862b-902a4d4cd4ac"},{"type":"BasicGroup","uuid":"e623deab-c83b-41e3-84a2-d9f1d46c5f17"},{"type":"SmartGroupUser","uuid":"a86d27d2-6bcd-4b94-bca5-fe16f4882855"},{"type":"ReferrerUser","uuid":"5a2c1d70-1255-4a45-95f3-a3aa3a2771fb"},{"type":"InstitutionUser","uuid":"ea77208c-eba1-49cf-a446-5d73daccdfad","customerRecords":[{"customerDomain":"ALM-CU","customerNumber":"TESTOHIOSTATECOCHRANE"}]},{"type":"SmartGroupUser","uuid":"da88d808-3f7b-4bde-9210-10862b6d121b"},{"type":"SmartGroupUser","uuid":"8c72a733-117a-4bc9-a682-13475f13e6a3"},{"type":"SmartGroupUser","uuid":"756fc162-8722-461f-a077-ebffec4f4fae"},{"type":"SmartGroupUser","uuid":"cf9c85b9-7f3b-4309-aeaa-c41669cabe3b"},{"type":"SmartGroupUser","uuid":"db8b8d10-1aed-4809-b3ee-70938c569014"},{"type":"SmartGroupUser","uuid":"cdce41c2-a8de-4a64-a4d9-a85caaaa2314"},{"type":"ReferrerUser","uuid":"6401b279-b825-4f41-a389-04e29feb967f"},{"type":"SmartGroupUser","uuid":"39f911ce-44b6-4dba-9978-8b2e947a8eb0"},{"type":"RegionUser","uuid":"18971d33-e3f1-4194-be84-47668d10cf64"},{"type":"SmartGroupUser","uuid":"b7acda8c-ce18-451b-a68d-e14b72f9b5b8"},{"type":"SmartGroupUser","uuid":"055a2bdd-861f-4fa7-bd49-9773db7e0e3e"},{"type":"BasicGroup","uuid":"197fe835-5b5f-4f4e-b8e9-a74d68491a84"},{"type":"SmartGroupUser","uuid":"b2dbfe27-ecae-4bb6-bb0d-d75e5caa3762"},{"type":"SmartGroupUser","uuid":"1a6297fb-6679-4882-a4c2-fdd124624edf"},{"type":"SmartGroupUser","uuid":"8032f17e-5050-4fb4-9c40-e1f6875d5c2b"},{"type":"BasicGroup","uuid":"2f6750d5-f13f-4356-939b-048ac1423e64"},{"type":"SmartGroupUser","uuid":"ab743440-628f-4964-9216-9983ad3beadf"},{"type":"SmartGroupUser","uuid":"a4187e00-f28e-4754-9a0f-1eb306fb0679"}],"publication":{"item":{"title":"γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation","doi":"10.1002/ijc.27863","access":"free","earliestDate":"2012-09-24","formats":["Abstract","Cited by","First page image","Full text","PDF","References","Supplementary Material"],"topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"group":{"doi":"10.1002/ijc.v132.8","access":"free","volume":"132","issue":"8","coverDate":"2013-04-15","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"}]},"series":{"title":"International Journal of Cancer","doi":"10.1002/(ISSN)1097-0215","access":"no","code":"10970215","issn":"0020-7136","eissn":"1097-0215","topics":[{"taxonomyUri":"gpt-sitename","topicLabel":"wly.onco.radthr_000091","topicUri":"wly.onco.radthr_000091"},{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pharmacology \u0026 Pharmaceutical Medicine","topicUri":"mdm0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Clinical Pharmacology \u0026 Therapeutics","topicUri":"mdm1"},{"taxonomyUri":"global-subject-codes","topicLabel":"Pathology","topicUri":"mdk0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Oncology \u0026 Radiotherapy","topicUri":"mdh0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Surgical Oncology","topicUri":"mdh2"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Oncology","topicUri":"mdh3"},{"taxonomyUri":"global-subject-codes","topicLabel":"Palliative Care","topicUri":"mdh4"},{"taxonomyUri":"global-subject-codes","topicLabel":"Hematology","topicUri":"mdc0"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"gpt-zonename","topicLabel":"ij-cancer_IJC","topicUri":"ij-cancer_ijc"}]}},"page":{"subPage":"Full Text","page":"Article/Chapter View","pageGroup":"Publication Pages","title":"title","errorCode":200},"tokens":{"tokenUsed":false}}</script>







<meta charset="UTF-8">




<meta name="robots" content="noarchive"/>





    














    






    <meta property="og:title" content="γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation"/>


    <meta property="og:type" content="Article"/>


        <meta property="og:url" content="https://onlinelibrary.wiley.com/doi/10.1002/ijc.27863"/>
    

        
        <meta property="og:image" content="https://onlinelibrary.wiley.com/cms/asset/68a073ac-2ec3-41dd-8f7c-f789287dec78/ijc.v132.8.cover.gif"/>
    

    <meta property="og:site_name" content="Wiley Online Library"/>



        

        <meta property="og:description" content="What's new? GSI-I is a γ-secretase inhibitor (GSI) that can induce apoptosis in some tumor cells. In this study of primary chronic lymphocytic leukemia (CLL) cells, the authors report that GSI I can ..."/>
    



    <meta name="viewport" content="width=device-width,initial-scale=1"/>






















    <link rel="preload" href="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js" as="script">
    <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js"></script>




    

    <meta name="citation_doi" content="10.1002/ijc.27863"/>

    <meta name="dc.identifier" content="10.1002/ijc.27863"/>




<meta name="citation_journal_title" content="International Journal of Cancer"><meta name="citation_title" content="&#x3b3;-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation"><meta name="citation_keywords" content="chronic lymphocytic leukemia cell apoptosis"><meta name="citation_keywords" content="&#x3b3;-secretase inhibitor I"><meta name="citation_keywords" content="proteasome"><meta name="citation_keywords" content="endoplasmic reticulum stress"><meta name="citation_keywords" content="Notch"><meta name="citation_volume" content="132"><meta name="citation_issue" content="8"><meta name="citation_firstpage" content="1940"><meta name="citation_lastpage" content="1953"><meta name="citation_publication_date" content="2013/04/15"><meta name="citation_online_date" content="2012/10/17"><meta name="citation_issn" content="1097-0215"><meta name="citation_language" content="en"><meta name="citation_author" content="Emanuela Rosati"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Rita Sabatini"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Filomena De Falco"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Beatrice Del Papa"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Franca Falzetti"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Mauro Di Ianni"><meta name="citation_author_institution" content="Department of Internal Medicine and Public Health, Chair of Hematology, University of L'Aquila, L'Aquila, Italy"><meta name="citation_author" content="Laura Cavalli"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Katia Fettucciari"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Andrea Bartoli"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_author" content="Isabella Screpanti"><meta name="citation_author_institution" content="Department of Molecular Medicine, University La Sapienza, Rome, Italy"><meta name="citation_author" content="Pierfrancesco Marconi"><meta name="citation_author_institution" content="Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy"><meta name="citation_abstract_html_url" content="https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.27863"><meta name="citation_fulltext_html_url" content="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.27863"><meta name="citation_pdf_url" content="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.27863"><meta name="citation_publisher" content="John Wiley & Sons, Ltd"><meta name="article_references" content="Rosati, E., Sabatini, R., De Falco, F., Del Papa, B., Falzetti, F., Di Ianni, M., Cavalli, L., Fettucciari, K., Bartoli, A., Screpanti, I. and Marconi, P. (2013), &#x3b3;-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. Int. J. Cancer, 132: 1940-1953. https://doi.org/10.1002/ijc.27863"><meta name="Description" content="Abstract &#x3b3;-Secretase inhibitors (GSIs) have been proposed for combined therapies of malignancies with a dysregulated Notch signaling. GSI I (Z-Leu-Leu-Nle-CHO) induces apoptosis of some tumor cells...">



<title>γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation - Rosati - 2013 - International Journal of Cancer - Wiley Online Library</title>










<link rel="stylesheet" type="text/css" href="/wro/l0m7~product.css">

<link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/icomoon/icomoon.woff?3a309d1f3a2b45cf678b" as="font" type="font/woff" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/open-sans/open-sans-v15-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/source-serif-pro/source-serif-pro-v5-latin-regular.woff2?3a309d1f3a2b45cf678b" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/build-3a309d1f3a2b45cf678b.css"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/print-3a309d1f3a2b45cf678b.css" media="print"/>




<script async src="/pb-assets/catchpoint-1549680351760.js"></script>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="shortcut icon" href="/favicon.ico">


<link rel="stylesheet" type="text/css" href="/pb-assets/hub-assets/pericles/hub-1645698573730.css">


<link rel="stylesheet" type="text/css" href="/pb-assets/css/iucr-1510734465460.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/readcube-1510565373110.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/dr-overrides-1611780866727.css">
<!-- link rel="stylesheet" type="text/css" href="/pb-assets/css/temporary-1525702334993.css" -->

<style>
/* PERICLES-7186: distorted cover images */
.journal-info-container .cover-image__image img {
    min-height: unset;
}

/* TEMPORARY CSS HACK TO FIX LIT-220590 */
.icon-icon-Rss::before {
    content: "\e629";
}

/* TEMPORARY CSS TO FIX ALIGNMENT OF TOP AD IN RIGHT RAIL */
.publication-cover-info {
    margin-bottom: 20px;
}

.article-row-right > .pb-ad {
    margin-left: 0;
    margin-bottom: 10px;
}

/* TEMPORARY HACK FOR PERICLES-6763 */
.table-of-content .issue-item h2 {
    font-size: 16px;
}

.table-of-content .issue-item h2 a.issue-item__title {
    display: inline;
}

/* TEMPORARY CSS FOR PERICLES-7445 */

input.saml__consent__yes {
    background: #005274;
    font-size: 12px;
    font-size: .75rem;
    padding: 12px 20px;
    border-radius: 0;
    margin-top: 20px;
    margin-right: 10px;
    width: 100px;
}

input.saml__consent__yes:hover {
    background: #003951;
}

/* PERICLES-2166: Site-wide maintenance message */

.admin-message {
    background-color: #005274;
    color: white;
}

/* TEMPORARY CSS FOR STAY-CONNECTED SOCIAL MEDIA ICONS */
.stay-connected ul  {
    list-style: none;
    margin: 0;
    padding: 0;
}

.stay-connected i {
    margin-right: 10px;
    font-size: 25px;
    line-height: 55px;
}

.stay-connected i.icon-hubs-rg-icon,
.stay-connected i.icon-hubs-soundcloud-icon {
    font-size: 41px;
}

.stay-connected .icon-hubs-pinterest-icon:before {
    color: white;
}

.stay-connected .icon-hubs-pinterest-icon {
    background-color: #BD081C;
    border: solid #BD081C;
    border-width: 8px;
}

/* PERICLES-5833: TEMPORARY CSS TO ADJUST POSITION OF ADS */
.article-mpu-bottom .pb-ad {
    margin: 0 0 0 195px;
}


.article-mpu-top .pb-ad {
    padding-top: 20px;
    margin: 0 0 -35px 0;
}

.banner-wrapper .pb-ad {
    padding: 0;
}

/* TEMPORARY CSS FOR THE SOCIETY MEMBER LOGIN PAGE */
.society-member-login .widget__header,
.society-member-login .show-registration,
.society-member-login .show-request-reset-password {
    display: none;
}

.society-member-login .login-form {
    margin-top: 20px;
}

.society-member-login .widget__body .input-group+.input-group {
    margin-top: 15px;
}


/* TEMPORARY CSS TO HIDE FPI IN TOP CONTENT ACTION WIDGET */
.top-content .firstPageImage {
	display: none;
}


.custom-page-pericles .main-content :target:before {
	content: "";
	display: block;
	height: 140px;
	margin: -140px 0 0;
}

/* PERICLES-4777: TEMPORARY CSS TO HIDE OPTIONS IN THE SIDEBAR ON MRW PAGES */
.journal-resources li#TableofContents,
.journal-resources li#Topics,
.journal-resources li#ArticleTitlesAZ {
	display: none;
}

/* TEMPORARY FIX FOR UNWANTED MARGIN BELOW COVER IMAGES ON BOOK SERIES PAGES */
.remove-margin .cover-image {
	margin: 0;
}

/* TEMPORARY FIX TO MAKE IT POSSIBLE TO EDIT RICH TEXT WIDGETS IN SLIDESHOWS */
.bs .modal-backdrop {
	display: none;
}

/* TEMPORARY FIX FOR MENU POSITION */
.hubpage-menu nav {
	padding-bottom: 0;
	position: relative;
}

/* TEMPORARY FOR MARGIN AROUND ADS */
.advert.advert-leaderboard {
	margin: 15px 0;
}

.banner-wrapper {
	box-shadow: none;
}

/* TEMPORARY TO FIX OVERFLOW FOR P IN JOURNAL-NEWS SLIDESHOWS */
.journal-news .slide-item p {
	overflow: unset;
}

/* EDITOR HIGHLIGHTS CSS */
div.ancillary-content.relateditem div.content {
	height: 10em;
}
div.ancillary-content.listitem div.content {
	height: 4em;
}

/* TEMPORARY Fix heading on Topical Index widget for MRWs */
.topical-index h2 {
    margin: 15px 0;
    font-size: 1.75rem;
    line-height: 28px;
    color: #1c1d1e;
    font-family: Source Serif Pro,serif;
    font-weight: normal;
}

/* PERICLES-7288 */
.issue-supplementary-files, .cover-image__virtual-issue {
    margin-bottom: 15px;
}

/* PERICLES-8875 */
.journal-news .slide-item img {
    float: left;
    margin-right: 10px;
}

/* DO NOT REMOVE */
li[heading="Restore Points"].ng-isolate-scope,
li[heading="Disable Widgets"].ng-isolate-scope {
    display: none!important;
}

.modal-header .widgetOrigin {
    display: none;
}

/* PERICLES-10090 */
.cover-image__image img {
    max-width: 150px;
    max-height: 150px;
}

/* LIT-282003 */
.journal-info-container span.info_value:after {
    content: '\003B';
}

.journal-info-container span.info_value:last-child:after {
    content: '';
}

/* LIT-299510 */
h1.citation__title {
    font-size: 22px;
    font-size: 1.375rem;
}

@media (max-width: 991px) {
    h1.citation__title {
        font-size: 18px;
        font-size: 1.125rem;
    }
    h1.citation__title:after {
        content: "";
    }
}

/* LIT-295816 */
.search__item .item__body .meta__details a.publication_meta_serial:after {
    content: "";
    margin: 0;
}
.search__item .item__body .meta__details a.publication_meta_volume_issue:before {
    content: "|";
    margin-left: 4px;
    margin-right: 4px;
}

/* PPV */
.cart-indicator__wrapper {
    padding: 0;
}

/* TrendMD Test */
#article__content #trendmd-suggestions{
    margin-top: 40px !important;
    border-top: 1px solid #ddd;

}
body #article__content .trendmd-widget-container {
    margin-top: 20px !important;
}

body #article__content .trendmd-widget-header__heading{
    font-size: 20px !important;
    margin-bottom: 30px !important
}
body #article__content .trendmd-widget-list-item__link, body #article__content .trendmd-widget-list-item__meta{
    font-family:'Open Sans', arial, sans-serif !important;
}
body #article__content .trendmd-widget{
	font-size:16px !important;
}
body #article__content .trendmd-widget-list-item{
	margin-bottom:24px !important;
}
body #article__content .trendmd-widget-list-item__link{
	color: #005293 !important;
}
body #article__content .trendmd-widget-list-item__meta{
	color: #5d5d5d !important;
	font-size:14px !important;
	margin-top:3px !important;
}
body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
	width: 47% !important;
}

@media (max-width: 450px) {
	body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
		width: 95% !important;
	}
}

#pane-pcw-related .trendmd-widget-header__heading{
	font-size: 18px !important;
	font-family:'Open Sans', arial, sans-serif !important;
}
#pane-pcw-related .trendmd-widget-container{
	padding:0 20px !important;
}
#pane-pcw-related .trendmd-widget-list-item__link{
	 font-family:'Open Sans', arial, sans-serif !important;
	 font-size:14px !important;
	 color: #005293 !important;
	 display:block;
	 margin-bottom: 5px !important;
}
#pane-pcw-related .trendmd-widget-list-item__meta{
	font-family:'Open Sans', arial, sans-serif !important;
	color:#666 !important;
}
#pane-pcw-related .trendmd-widget-list-item{
	margin-bottom:20px !important;
}


</style>

<!-- The Adobe DTM script. Must come after the digitalData object -->
<script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-c1ac050bbdc647f13a62578e71f0d817f8a6cbb5.js"></script>

<!-- Google Search Console verification -->
<meta name="google-site-verification" content="ffz4i4DxIJCdGpRXe0XN6KG6o4FYI-nnFW9I_dg8piM" />

<!-- KRUX Implementation-->
<script class="kxct" data-id="JMOONjNh" data-timing="async" data-version="1.9" type="text/javascript">

	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments )
	}).q = []);

	( function () {
		var k , m , s , src;
		k = document.createElement ( 'script' );
		k.type 	= 'text/javascript';
		k.async = true;
		src = ( m = location.href.match ( /\bkxsrc=([^&]+)/ )) && decodeURIComponent ( m [ 1 ]);
		k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test ( src ) ? src : src === 'disable' ? '' : ( location.protocol === 'https:'?'https:':'http:' ) + '//cdn.krxd.net/controltag?confid=JMOONjNh';
		s = document.getElementsByTagName ( 'script' ) [ 0 ];
		s.parentNode.insertBefore ( k , s );
	} ());
</script>

<!-- KRUX Implementation cont'd -->
<script type="text/javascript">
	window.Krux || (( Krux = function () {
		Krux.q.push ( arguments );
	}).q = []);

	( function () {
		function retrieve ( n ) {
			var m , k = 'kx' + n;
			if ( window.localStorage ) {
				return window.localStorage [ k ] || '';
			} else if ( navigator.cookieEnabled ) {
				m = document.cookie.match ( k + '=([^;]*)' );
				return ( m && unescape ( m [ 1 ])) || '';
			} else {
				return '';
			}
		}

		Krux.user = retrieve ( 'user' );
		Krux.segments = retrieve ( 'segs' ) && retrieve ( 'segs' ).split ( ',' ) || [];
	}) ();
</script>

<!-- Grapeshot Implementation -->
<script>
	var gs_channels = 'default';
</script>

<script src="//wiley.grapeshot.co.uk/main/channels.cgi?url=https://onlinelibrary.wiley.com/doi/10.1002/ijc.27863" async></script>

<!-- DoubleClick Implementation -->
<script type="text/javascript">
	var $WileyGooglePublisherID = 2215;

	if (!$DoubleClickSite) {
		switch("pericles") {
	  		case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickSite = "wly.agriculture_000018";
				break;
			case "afspubs":
				var $DoubleClickSite = "wly.aqua.fish_000017";
				break;
			case "aasldpubs":
  				var $DoubleClickSite = "wly.gastro.hep_000059";
  				break;
			case "headachejournal":
  				var $DoubleClickSite = "wly.neurology_000086";
  				break;
  			case "wildlife":
				var $DoubleClickSite = "wly.zoology_000120";
				break;
			default:
				var $DoubleClickSite = "undefined-site";
		};
  	};

	if (!$DoubleClickZone) {
		switch("pericles") {
			case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickZone = "Agriculture_ACSESS_Hub";
				break;
			case "afspubs":
				var $DoubleClickZone = "AFS_HUB";
				break;
			case "aasldpubs":
				var $DoubleClickZone = "AASLD-pubs_HUB";
				break;
			case "headachejournal":
				var $DoubleClickZone = "headache_HUB";
				break;
			case "wildlife":
				var $DoubleClickZone = "tws_HUB";
				break;
			default:
				var $DoubleClickZone = "undefined-zone";
		};
	};

	var $GooglePublisherCategory = "/" + $WileyGooglePublisherID + "/" + $DoubleClickSite + "/" + $DoubleClickZone;
</script>

<script>
	var googletag = googletag || {};

	googletag.cmd = googletag.cmd || [];

	( function () {

		var gads = document.createElement ( 'script' ) ,
		node = document.getElementsByTagName ( 'script' ) [ 0 ] ;

		gads.async = true;
		gads.src = document.location.protocol + '//www.googletagservices.com/tag/js/gpt.js';

		node.parentNode.insertBefore ( gads , node );

	}) ();
</script>

<script>
	googletag.cmd.push ( function () {

		var sizes = {
			leaderboard : googletag.sizeMapping ()
				.addSize ([ 300 , 100 ] , [ 300 , 50 ])
				.addSize ([ 740 , 100 ] , [ 728 , 90 ])
				.addSize ([ 0 , 0 ] , 'fluid')
				.build () ,
			rail : googletag.sizeMapping ()
				.addSize ([ 0 , 0 ] , [ 300 , 250 ])
				.build (),
			interstitial : googletag.sizeMapping ()
							.addSize ([ 0 , 0 ] , [ 640 , 480 ])
							.build ()

		};


		gptPage = window.digitalData && digitalData.page && digitalData.page.page ? digitalData.page.page : "blank";
		gptSubPage = window.digitalData && digitalData.page && digitalData.page.subPage ? digitalData.page.subPage : "blank";


		function gptClean(gptText){
			if(typeof(gptText)=="string"){
				gptText = gptText.replace(/\&/g,'%26');


				return gptText.replace(/\^|\*|#|\$|\"|\'|\=|\,|\!|\+|\~|\;|\(|\)|\<|\>|\[|\]|\?|\%|\:|\@|\;|\&|\||\{|\}|\\|/g,'');

			}
			return "blank";
		}


		googletag.pubads ()
			.setTargeting ( 'property' 	, 'value-of-property' 	) 	// Change and duplicate this line for as many additional keywords to send
			.setTargeting ( 'doi' , gptClean('10.1002/ijc.27863')) // Publication DOI
			.setTargeting ( 'gs_cat' 	, gs_channels 		) 	// Grapeshot
			.setTargeting ( 'ksg' 		, Krux.segments 	) 	// Krux
			.setTargeting ( 'kuid' 		, Krux.user 		) 	// Krux
			.setTargeting ( 'pbPage', gptClean(gptPage) )
			.setTargeting ( 'pbSubPage', gptClean(gptSubPage) )
			.setTargeting ( 'urlpath', gptClean(document.location.pathname));

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-leaderboard' )
			.defineSizeMapping ( sizes.leaderboard )
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-1' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-1')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-2' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-2')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-video' )
			.defineSizeMapping ( sizes.interstitial )
			.setTargeting ( 'Position', 'advert-video')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );


		googletag.pubads ().enableSingleRequest ();
		googletag.enableServices ();
	});
	//]]>
</script>

<script src="//validate.onecount.net/js/all.min.js#cff4b10c3a3d5cc9bbb7e2b9292cc66eae1deafa"></script>
<script>
	try {
		GCN.onecount.setTargeting();
	} catch (e) {
	}
</script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65604cf31ed0e4d9","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.1","si":10}'></script>
<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65cb04cf2c4898e7","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>
<script async src='/cdn-cgi/bm/cv/669835187/api.js'></script><script type="text/javascript">(function(){window['__CF$cv$params']={r:'65d1a8e0c92cd32a',m:'67aa9be47daef6356de6609e1160d5d3eaa5ffa2-1623318251-1800-AaebyrEA/0jUMhvUAOk0j/wUR0nsoq6UdvlB2Moolrehflza6iixm14P9MalQ+R8Vryip4agQZ71w0jrBJXqJEfdW+xLLufgGKZPRxJhvd4I3qMsuBop2ACJDvs+WtlCjNmSktt5c/WE8XBjCql0oD4=',s:[0x5aebccbc48,0x5cc5562061],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"65d1a8e0c92cd32a","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.5.2","si":10}'></script>






    <!-- Get whether TNSI is in live or test mode -->
    
    <!-- Get the configured TNSI Javascript version number -->
    
    <!-- Get the configured TNSI MerchantID -->
    
    <!-- Add "TEST" to beginning of merchant ID when running in test mode -->
    

    










    
    

    
    
    
    
    <!-- loading Javascript for using the persistence Service -->
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        function getParameter(parameterName) {
            let result = null,
                tmp = [];
            location.search
                .substr(1)
                .split("&")
                .forEach(function (item) {
                    tmp = item.split("=");
                    if (tmp[0] === parameterName) result = tmp[1];
                });
            return result;
        }

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            queryParamsDelimiter: encodeURIComponent('?'),

            getWAYFLessUrl: function (entityId) {
                let redirectURL = getParameter('redirectUri');
                if(redirectURL == null){
                    redirectURL = encodeURIComponent(this.returnURL);
                }
                if(redirectURL.indexOf('saml_referrer') < 0){
                    redirectURL += encodeURIComponent(((redirectURL.indexOf(this.queryParamsDelimiter) !== -1) ? '&' : '?') + 'saml_referrer');
                }
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + redirectURL;
            },
            retrieveEntity: function () {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve, reject) {
                    ps.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    ps.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId, entityTitle) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId, entityTitle: entityTitle, eventGroupKey: '9c1bdedf-c126-426e-b4af-f6a7fb9a043b'}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (let i in allSsoInstitutions) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID, ssoInstitution.entity.title)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>



    <script type="text/javascript">
        (function() {
            function riskifiedBeaconLoad() {
                var store_domain = 'https://onlinelibrary.wiley.com';
                var session_id = 'aaaX9G5-ds_aIaX1geD9x';
                var url = ('https:' == document.location.protocol ? 'https://' : 'http://')
                    + "beacon.riskified.com?shop=" + store_domain + "&sid=" + session_id;
                var s = document.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = url;
                var x = document.getElementsByTagName('script')[0];
                x.parentNode.insertBefore(s, x);
            }
            if (window.attachEvent)
                window.attachEvent('onload', riskifiedBeaconLoad)
            else
                window.addEventListener('load', riskifiedBeaconLoad, false);
        })();
    </script>


<script>
    var digitalData = window.digitalData ? window.digitalData : {};
    digitalData.page.title = "γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation - Rosati - 2013 - International Journal of Cancer - Wiley Online Library";
</script><script async src='/cdn-cgi/bm/cv/669835187/api.js'></script></head>
<body class="pb-ui">

<div class="skip-links">
    <ul class="rlist">
        
                <li><a href="#article__content" tabindex="1">Skip to Article Content</a></li>
                <li><a href="#pane-pcw-detailscon" tabindex="1">Skip to Article Information</a></li>
            
    </ul>
</div>







    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="pageHeader" data-widget-id="62175478-b98a-43d5-90f2-1f2045ac1a7e" class="pageHeader">
        



        
        <header class="page-header">
    <div data-pb-dropzone="main">
    









        <div data-widget-def="ux3-layout-widget" data-widget-id="bb5b5e2c-d3d6-4015-b586-eeade38f59d4" class="admin-message">
        



        
        <div class="container"><div class="row"><div>



        
        



        <div class="pb-ad">
            <div style="background=blue;">
    <div class="container">
        <p style="text-align: center;"><b>Working off-campus?</b> Learn about our <a href="/action/clickThrough?id=101169&url=https%3A%2F%2Fonlinelibrary.wiley.com%2Fresearchers%2Fread%2Faccess-options&loc=%2Fdoi%2F10.1002%2Fijc.27863&pubId=57778996&placeholderId=1029&productId=1011" target="_blank" tabindex="2"><font color="white"><u>remote access options</u></font></a></p>
    </div>
</div>
        </div>
    

</div></div></div>

        </div>
    




        
        <div class="container"><div class="row"><div class="contents col-sm-12 col-md-12">



        
        <div class="pull-left">









        <div data-widget-def="ux3-general-image" data-widget-id="ff262197-0fb8-4973-aaa2-2fceba4b5a61" class="logo-container hidden-xs hidden-sm hidden-md">
        



        
        <a href="/" title="Wiley Online Library"><img id="mainLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png"/></a>

        </div>
    










        <div data-widget-def="ux3-general-image" data-widget-id="9a75b789-224c-4745-833a-930cf6c36f35" class="logo-container-mobile hidden-lg hidden-md hidden-sm">
        



        
        <a href="/" title="Wiley Online Library"><img id="mobileLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/mobilehublogo-1518781861020.png"/></a>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="UX3QuickSearchWidget" data-widget-id="48175bb0-0f70-46e6-bb89-7e2781fdb8e4" class="header-quicksearch">
        



        
        <div class="quick-search-wrapper"><a href="#" title="search" aria-label="Search" class="quick-search__item"><i aria-hidden="true" class="icon-search"></i><span class="quick-search__item__arrow"></span></a><div data-linkto-page="true" class="quick-search quickSearchFormContainer"><div class="main-search-field-wrapper"><div class="tab clearfix"><input type="search" placeholder="Search" value="" tabindex="13" class="fakeQSInput quickSearchFilter"/><label for="search-within" class="sr-only">Search within</label><select name="search-within" id="search-within" tabindex="10" class="search-within"><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c0" data-url="thisCategory" data-value="10970215">This Journal</option><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c1" data-url="https://onlinelibrary.wiley.com">Anywhere</option></select><ul role="tablist" class="rlist tab__content"><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c0" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c0-con" role="tab" class="tab__pane quick-search-pane__anywhere active"><form action="/action/doSearch" name="thisJournalQuickSearch" method="get" title="Quick Search"><div class="input-group option-0"><label for="searchField0" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField0" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><input type="hidden" name="SeriesKey" value="10970215"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced?publication=10970215#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c1" aria-labelledby="pane-67065c09-4a88-49cd-934c-ac707951d35c1-con" role="tab" class="tab__pane quick-search-pane__anywhere"><form action="https://onlinelibrary.wiley.com/action/doSearch" name="defaultQuickSearch" method="get" title="Quick Search"><div class="input-group option-1"><label for="searchField1" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField1" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li></ul></div></div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="5ef13ed1-f4ac-4b62-a426-07ec9576a586" class="cart-indicator__wrapper">
        



        
        <div class="pull-left">









        <div data-widget-def="eCommerceCartIndicatorWidget" data-widget-id="4a9f7c04-a273-4a25-91fb-8e7bd9970288" class="cart-indicator__wrapper">
        



        
        















<div class="eCommerceCartIndicatorWidget">
    
            
        
</div>

        </div>
    
</div><div class="pull-right">









        <div data-widget-def="literatumNavigationLoginBar" data-widget-id="d384ca92-7137-45d6-b3c2-78c9c0a98c2b" class="login-bar-container">
        



        
        




    








        




    









    <div class="loginBar login-open">
        <a href="/action/showLogin?uri=%2Fdoi%2F10.1002%2Fijc.27863&amp;aria-label=Log+in+or+Register" class="show-login" role="button" uri="/doi/10.1002/ijc.27863" aria-label="Log in or Register">
            <span class="icon-profile_empty"></span>
            <span class="sign-in-label">Login / Register</span>
        </a>
            
    </div>


    


        </div>
    
</div>

        </div>
    
</div>
</div></div></div>
    </div>
</header>


        </div>
    










        <div data-widget-def="pageBody" data-widget-id="72100436-7a82-49fc-933b-c6c9d8c42914" class="pageBody article-page-tablet body-text">
        



        
        <main id="main-content" tabindex="-1">
    <!--begin pagefulltext-->
    <div class="page-body pagefulltext">
        <div data-pb-dropzone="main">
        



        
        <div>









        <div data-widget-def="literatumAd" data-widget-id="0220a30b-90c0-4b51-8637-141edf12f86a" class="banner-wrapper">
        



        
        



        <div class="pb-ad">
            <aside role="complementary">
		<div id="advert-leaderboard" class="advert advert-leaderboard">
			<script>
				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-leaderboard' );
				});
			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1013&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D728x90%26amp%3Btile%3D1%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27863&pubId=57778996&placeholderId=1015&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=728x90&amp;tile=1&amp;c=$random">
				</a>
			</noscript>
		</div>
	</aside>
        </div>
    


        </div>
    




        
        
</div>










        <section data-widget-def="ux3-layout-widget" data-widget-id="0f7bccba-8328-4dbd-a1fa-e84c526dd9ab">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">



        
        <div>



        
        <article data-figures="/action/ajaxShowFigures?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27863&amp;pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27863&amp;pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2" data-related="/action/ajaxShowRecommended?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27863&amp;pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-details="/action/ajaxShowPubInfo?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fijc.27863&amp;pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-mathjax="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_HTMLorMML"><div class="row article-row"><div id="article__content" tabindex="-1" class="col-sm-12 col-md-8 col-lg-8 article__content article-row-left"><div data-pb-dropzone="mrwBannerDropZone" class="mrw-banner-dropzone">



        
        
</div><div class="article-citation"><div class="citation">
   <div class="pb-dropzone" data-pb-dropzone="publicaitonContent-series-title"><div id="journal-banner-text" class="journal-banner-text"><a href="/journal/10970215" title="International Journal of Cancer homepage">International Journal of Cancer</a></div><a href="/toc/10970215/2013/132/8" class="volume-issue">Volume 132, Issue 8</a><span class="citation__page-range"> p. 1940-1953</span><a href="/journal/10970215" title="International Journal of Cancer homepage" class="citation--logo"><img id="journal-banner-image" test="test-value" alt="International Journal of Cancer" src="/pb-assets/journal-banners/10970215-1635434903757.jpg" class="journal-banner-image"></a><script>var image = new Image();

image.onerror = function() {
  // if the image does not exist
  //document.getElementById("journal-banner-text").style.marginBottom = "15px";
  document.getElementById("journal-banner-text").style.fontSize = "22px";
  document.getElementById("journal-banner-image").style.display = "none";
}

image.src = "/pb-assets/journal-banners/10970215-1635434903757.jpg";</script></div>
   <div class="doi-access-container clearfix"><span class="primary-heading"><span class="primary-heading">Cancer Therapy</span></span><div class="doi-access-wrapper"><div class="free-access access-type"><i aria-hidden="true" class="icon-icon-lock_open"></i><div class="doi-access">Free Access</div></div></div></div>
   <h1 class="citation__title">γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation</h1>
   <div class="accordion corrections-container">
      <h2 class="corrections-title"><a id="single-accordion-controller-idd14195106" href="#" title="Single Accordion Controller" class="accordion__control corrections-label w-slide__btn" data-slide-target="#d14195106" aria-expanded="false" role="button"><i aria-hidden="true" class="info-icon icon-notice"></i><span class="corrections-label__text">Correction(s) for this article</span><i aria-hidden="true" class="icon-arrow icon-keyboard_arrow_down"></i></a></h2>
      <div style="display: none;" id="d14195106" class="accordion__content corrections-body hidden-xs hidden-sm" role="region" aria-labelledby="single-accordion-controller-idd14195106">
         <ul class="rlist separator corrections-container__list">
            <li><a href="/doi/10.1002/ijc.29623">
   <h6>Erratum</h6></a><div class="parent-item">
   <ul class="rlist--inline separator">
      <li><span class="comma">Volume 137</span><span class="comma">Issue 8</span><span>International Journal of Cancer</span></li>
      <li><span>pages: E17-E17</span></li>
      <li>First Published online: August 7, 2015</li>
   </ul>
</div></li>
         </ul>
      </div>
   </div>
   <div class="loa comma visible-xs mobile-authors loa-authors-trunc">
      <div class="comma__list"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Rosati%2C+Emanuela" class="author-name accordion-tabbed__control" data-id="am1" data-db-target-for="am1" aria-controls="am1" aria-haspopup="true" id="am1_Ctrl" role="button"><span>Emanuela Rosati<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am1" aria-labelledby="am1_Ctrl" role="region" id="am1">
               <p class="author-type mb-1">Corresponding Author</p>
               <p class="author-name">Emanuela Rosati</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="mailto:erosati@unipg.it"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span>erosati@unipg.it</span></a></li>
               </ul>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p>
               <p>Tel.: +39-075-5855830, Fax: +39-075-5855827</p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, Via Enrico dal Pozzo, Padiglione-W, 06126, Perugia, Italy<a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Rosati%2C+Emanuela">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Sabatini%2C+Rita" class="author-name accordion-tabbed__control" data-id="am2" data-db-target-for="am2" aria-controls="am2" aria-haspopup="true" id="am2_Ctrl" role="button"><span>Rita Sabatini</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am2" aria-labelledby="am2_Ctrl" role="region" id="am2">
               <p class="author-name">Rita Sabatini</p>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Sabatini%2C+Rita">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=de+Falco%2C+Filomena" class="author-name accordion-tabbed__control" data-id="am3" data-db-target-for="am3" aria-controls="am3" aria-haspopup="true" id="am3_Ctrl" role="button"><span>Filomena De Falco</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am3" aria-labelledby="am3_Ctrl" role="region" id="am3">
               <p class="author-name">Filomena De Falco</p>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p>
               <p>R.S. and F.D.F. contributed equally to this study</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=de+Falco%2C+Filomena">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=del+Papa%2C+Beatrice" class="author-name accordion-tabbed__control" data-id="am4" data-db-target-for="am4" aria-controls="am4" aria-haspopup="true" id="am4_Ctrl" role="button"><span>Beatrice Del Papa</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am4" aria-labelledby="am4_Ctrl" role="region" id="am4">
               <p class="author-name">Beatrice Del Papa</p>
               <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=del+Papa%2C+Beatrice">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Falzetti%2C+Franca" class="author-name accordion-tabbed__control" data-id="am5" data-db-target-for="am5" aria-controls="am5" aria-haspopup="true" id="am5_Ctrl" role="button"><span>Franca Falzetti</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am5" aria-labelledby="am5_Ctrl" role="region" id="am5">
               <p class="author-name">Franca Falzetti</p>
               <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Falzetti%2C+Franca">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Di+Ianni%2C+Mauro" class="author-name accordion-tabbed__control" data-id="am6" data-db-target-for="am6" aria-controls="am6" aria-haspopup="true" id="am6_Ctrl" role="button"><span>Mauro Di Ianni</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am6" aria-labelledby="am6_Ctrl" role="region" id="am6">
               <p class="author-name">Mauro Di Ianni</p>
               <p>Department of Internal Medicine and Public Health, Chair of Hematology, University of L'Aquila, L'Aquila, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Di+Ianni%2C+Mauro">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Cavalli%2C+Laura" class="author-name accordion-tabbed__control" data-id="am7" data-db-target-for="am7" aria-controls="am7" aria-haspopup="true" id="am7_Ctrl" role="button"><span>Laura Cavalli</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am7" aria-labelledby="am7_Ctrl" role="region" id="am7">
               <p class="author-name">Laura Cavalli</p>
               <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Cavalli%2C+Laura">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Fettucciari%2C+Katia" class="author-name accordion-tabbed__control" data-id="am8" data-db-target-for="am8" aria-controls="am8" aria-haspopup="true" id="am8_Ctrl" role="button"><span>Katia Fettucciari</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am8" aria-labelledby="am8_Ctrl" role="region" id="am8">
               <p class="author-name">Katia Fettucciari</p>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Fettucciari%2C+Katia">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Bartoli%2C+Andrea" class="author-name accordion-tabbed__control" data-id="am9" data-db-target-for="am9" aria-controls="am9" aria-haspopup="true" id="am9_Ctrl" role="button"><span>Andrea Bartoli</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am9" aria-labelledby="am9_Ctrl" role="region" id="am9">
               <p class="author-name">Andrea Bartoli</p>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Bartoli%2C+Andrea">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Screpanti%2C+Isabella" class="author-name accordion-tabbed__control" data-id="am10" data-db-target-for="am10" aria-controls="am10" aria-haspopup="true" id="am10_Ctrl" role="button"><span>Isabella Screpanti</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am10" aria-labelledby="am10_Ctrl" role="region" id="am10">
               <p class="author-name">Isabella Screpanti</p>
               <p>Department of Molecular Medicine, University La Sapienza, Rome, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Screpanti%2C+Isabella">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Marconi%2C+Pierfrancesco" class="author-name accordion-tabbed__control" data-id="am11" data-db-target-for="am11" aria-controls="am11" aria-haspopup="true" id="am11_Ctrl" role="button"><span>Pierfrancesco Marconi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="am11" aria-labelledby="am11_Ctrl" role="region" id="am11">
               <p class="author-name">Pierfrancesco Marconi</p>
               <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Marconi%2C+Pierfrancesco">Search for more papers by this author</a></div></span></div>
   </div>
   <div class="loa-wrapper loa-authors hidden-xs desktop-authors">
      <div id="sb-1" class="accordion">
         <div class="comma__list">
            <div class="accordion-tabbed"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Rosati%2C+Emanuela" class="author-name accordion-tabbed__control" data-id="a1" data-db-target-for="a1" aria-controls="a1" aria-haspopup="true" id="a1_Ctrl" role="button"><span>Emanuela Rosati<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a1" aria-labelledby="a1_Ctrl" role="region" id="a1">
                     <p class="author-type mb-1">Corresponding Author</p>
                     <p class="author-name">Emanuela Rosati</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="mailto:erosati@unipg.it"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span>erosati@unipg.it</span></a></li>
                     </ul>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p>
                     <p>Tel.: +39-075-5855830, Fax: +39-075-5855827</p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, Via Enrico dal Pozzo, Padiglione-W, 06126, Perugia, Italy<a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Rosati%2C+Emanuela">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Sabatini%2C+Rita" class="author-name accordion-tabbed__control" data-id="a2" data-db-target-for="a2" aria-controls="a2" aria-haspopup="true" id="a2_Ctrl" role="button"><span>Rita Sabatini</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a2" aria-labelledby="a2_Ctrl" role="region" id="a2">
                     <p class="author-name">Rita Sabatini</p>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Sabatini%2C+Rita">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=de+Falco%2C+Filomena" class="author-name accordion-tabbed__control" data-id="a3" data-db-target-for="a3" aria-controls="a3" aria-haspopup="true" id="a3_Ctrl" role="button"><span>Filomena De Falco</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a3" aria-labelledby="a3_Ctrl" role="region" id="a3">
                     <p class="author-name">Filomena De Falco</p>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p>
                     <p>R.S. and F.D.F. contributed equally to this study</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=de+Falco%2C+Filomena">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=del+Papa%2C+Beatrice" class="author-name accordion-tabbed__control" data-id="a4" data-db-target-for="a4" aria-controls="a4" aria-haspopup="true" id="a4_Ctrl" role="button"><span>Beatrice Del Papa</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a4" aria-labelledby="a4_Ctrl" role="region" id="a4">
                     <p class="author-name">Beatrice Del Papa</p>
                     <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=del+Papa%2C+Beatrice">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Falzetti%2C+Franca" class="author-name accordion-tabbed__control" data-id="a5" data-db-target-for="a5" aria-controls="a5" aria-haspopup="true" id="a5_Ctrl" role="button"><span>Franca Falzetti</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a5" aria-labelledby="a5_Ctrl" role="region" id="a5">
                     <p class="author-name">Franca Falzetti</p>
                     <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Falzetti%2C+Franca">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Di+Ianni%2C+Mauro" class="author-name accordion-tabbed__control" data-id="a6" data-db-target-for="a6" aria-controls="a6" aria-haspopup="true" id="a6_Ctrl" role="button"><span>Mauro Di Ianni</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a6" aria-labelledby="a6_Ctrl" role="region" id="a6">
                     <p class="author-name">Mauro Di Ianni</p>
                     <p>Department of Internal Medicine and Public Health, Chair of Hematology, University of L'Aquila, L'Aquila, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Di+Ianni%2C+Mauro">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Cavalli%2C+Laura" class="author-name accordion-tabbed__control" data-id="a7" data-db-target-for="a7" aria-controls="a7" aria-haspopup="true" id="a7_Ctrl" role="button"><span>Laura Cavalli</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a7" aria-labelledby="a7_Ctrl" role="region" id="a7">
                     <p class="author-name">Laura Cavalli</p>
                     <p>Department of Clinical and Experimental Medicine, Hematology and Clinical Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Cavalli%2C+Laura">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Fettucciari%2C+Katia" class="author-name accordion-tabbed__control" data-id="a8" data-db-target-for="a8" aria-controls="a8" aria-haspopup="true" id="a8_Ctrl" role="button"><span>Katia Fettucciari</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a8" aria-labelledby="a8_Ctrl" role="region" id="a8">
                     <p class="author-name">Katia Fettucciari</p>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Fettucciari%2C+Katia">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Bartoli%2C+Andrea" class="author-name accordion-tabbed__control" data-id="a9" data-db-target-for="a9" aria-controls="a9" aria-haspopup="true" id="a9_Ctrl" role="button"><span>Andrea Bartoli</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a9" aria-labelledby="a9_Ctrl" role="region" id="a9">
                     <p class="author-name">Andrea Bartoli</p>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Bartoli%2C+Andrea">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Screpanti%2C+Isabella" class="author-name accordion-tabbed__control" data-id="a10" data-db-target-for="a10" aria-controls="a10" aria-haspopup="true" id="a10_Ctrl" role="button"><span>Isabella Screpanti</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a10" aria-labelledby="a10_Ctrl" role="region" id="a10">
                     <p class="author-name">Isabella Screpanti</p>
                     <p>Department of Molecular Medicine, University La Sapienza, Rome, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Screpanti%2C+Isabella">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/action/doSearch?ContribAuthorRaw=Marconi%2C+Pierfrancesco" class="author-name accordion-tabbed__control" data-id="a11" data-db-target-for="a11" aria-controls="a11" aria-haspopup="true" id="a11_Ctrl" role="button"><span>Pierfrancesco Marconi</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">, </span><div class="author-info accordion-tabbed__content" data-db-target-of="a11" aria-labelledby="a11_Ctrl" role="region" id="a11">
                     <p class="author-name">Pierfrancesco Marconi</p>
                     <p>Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia, Italy</p><a class="moreInfoLink" href="/action/doSearch?ContribAuthorRaw=Marconi%2C+Pierfrancesco">Search for more papers by this author</a></div></span></div>
         </div>
      </div>
   </div>
   <div class="epub-sections"><div class="epub-section"><span class="epub-state">First published: </span><span class="epub-date">24 September 2012</span></div>
      <div class="epub-section"><a class="epub-doi" aria-label="Digital Object Identifier" href="https://doi.org/10.1002/ijc.27863">https://doi.org/10.1002/ijc.27863</a></div><div class="epub-section cited-by-count"><span>Citations: <a href="#citedby-section">33</a></span></div></div>
   <div class="epub-sections">
      <div class="article-header__references-container no-truncate" id="fn1" tabindex="0"></div>
      <div class="article-header__references-container no-truncate" id="fn2" tabindex="0"></div>
   </div>
</div></div><div class="fixedCoolBar"><nav aria-label="Article navigation and tools" class="coolBar stickybar"><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><div class="coolBar__section"><a href="javascript:void(0)" data-db-target-for="article" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="article_Pop" role="button" id="article_Ctrl" class="coolBar__ctrl hidden-lg"><i class="icon-abstract"></i><span>About</span></a><div data-db-target-of="article" aria-labelledby="article_Ctrl" role="menu" id="article_Pop" class="coolBar__drop fixed rlist dropBlock__holder"><div data-target=".article-row-right .tab__nav, .coolBar--download" data-remove="false" data-targetClass="hidden-xs hidden-sm" data-toggle="transplant" data-direction="from" data-transplant="self" class="transplant showit"></div></div></div><div class="coolBar__section coolBar--sections"><a id="sections_Ctrl" href="javascript:void(0)" data-db-target-for="sections" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="sections_Pop" role="button" class="coolBar__ctrl"><i class="icon-list-unordered"></i><span>Sections</span></a><div data-db-target-of="sections" aria-labelledby="sections_Ctrl" role="menu" id="sections_Pop" class="coolBar__drop dropBlock__holder rlist fixed"></div></div></div><div class="coolBar__second rlist"><div class="coolBar__section coolBar--download PdfLink"><a href="/doi/epdf/10.1002/ijc.27863" title="ePDF" class="coolBar__ctrl pdf-download"><img src="/products/pericles/releasedAssets/images/pdf-icon.png" alt="PDF"/>PDF</a></div>



        
        <div class="relative"><a href="#" data-db-target-for="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" role="button" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" class="article-tools__ctrl"><i aria-hidden="true" class="icon-Icon_Tools"></i><span>Tools</span></a><div data-db-target-of="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" aria-labelledby="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" role="menu" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" class="article-tools__block fixed dropBlock__holder"><ul class="rlist w-slide--list"><li role="presentation" class="article-tool"><a href="https://onlinelibrary.wiley.com/action/rightsLink?doi=10.1002%2Fijc.27863&amp;mode=" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-permissions-key"></i><span>Request permission</span></a></li><li role="presentation" class="article-tool"><a href="/action/showCitFormats?doi=10.1002%2Fijc.27863" role="menuitem" target="_self"><i aria-hidden="true" class="icon-export-icon"></i><span>Export citation</span></a></li><li role="presentation" class="article-tool"><a href="/personalize/addFavoritePublication?doi=10.1002%2Fijc.27863" role="menuitem" target="_self"><i aria-hidden="true" class="icon-favorites"></i><span>Add to favorites</span></a></li><li role="presentation" class="article-tool"><a href="/action/addCitationAlert?doi=10.1002%2Fijc.27863" role="menuitem" target="_self"><i aria-hidden="true" class="icon-Icon_Track-citations"></i><span>Track citation</span></a></li></ul></div></div>




        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-51225be51b56b4c4"></script><div class="relative"><a id="share-access__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share-access__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><a id="share__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share__ctrl hidden"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><div data-db-target-of="dff42abe-4b17-4fe9-a9c5-625405cd1007" aria-labelledby="share-access__ctrl" role="menu" id="share_Pop" class="share__block dropBlock__holder fixed">



        
        <div data-share-access="/action/authorizeSharing?doi=10.1002/ijc.27863&amp;shareType=P2P" class="share-access hidden"><p>Give access</p><a href="#" data-toggle="modal" data-target="#shareAccess" class="share-access__link"><i class="icon-users"></i>Share full text access</a></div><div class="ux-modal-container share-access__modal"><div id="shareAccess" class="modal"><div class="modal__dialog"><div class="modal__header"><button type="button" data-dismiss="modal" class="close"><i aria-hidden="true" class="icon-close_thin"></i></button><p>Share full-text access</p></div><div class="modal__body"><form method="post"><fieldset><legend>Please review our <a href="https://onlinelibrary.wiley.com/termsAndConditions" target="_blank">Terms and Conditions of Use</a> and check box below to share full-text version of article.</legend><div class="input-group"><label for="terms-and-conditions" class="checkbox--primary"><input id="terms-and-conditions" type="checkbox" value="yes" required="" name="terms-and-conditions" data-ajax-link="/action/generateShareUrl?doi=10.1002/ijc.27863&amp;shareType=P2P&amp;format=FULL-TEXT" data-shareable-link=""/><span class="label-txt">I have read and accept the Wiley Online Library Terms and Conditions of Use</span></label></div></fieldset><hr class="separator"/><div class="shareable"><label>Shareable Link</label><p>Use the link below to share a full-text version of this article with your friends and colleagues. <a href="https://onlinelibrary.wiley.com/researchers/tools-resources/sharing" target="_blank" class="emphasis">Learn more.</a></p><div class="shareable__box"><div class="shareable__text"><div class="shareable__field"><span id="shareable__text"></span><textarea tabindex="-1" class="shareable__text-area"></textarea></div></div><button type="submit" disabled="" class="btn shareable__btn">Copy URL</button></div><div class="error shareable__error hidden"></div></div></form></div></div></div></div>
<p>Share a link</p><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter-t"></i>Twitter</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit-alien"></i>Reddit</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li></ul></div></div>
</div></div></nav></div><div id="accessDenialslot" class="accessDenialslot"></div><div class="article__body "><article>
   
   
   <div class="abstract-group">
      <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
         <h2 id="d14195272" class="article-section__header section__title main abstractlang_en main">Abstract</h2>
         <div class="article-section__content en main">
            
            <p>γ-Secretase inhibitors (GSIs) have been proposed for combined therapies of malignancies with a dysregulated Notch signaling. GSI I (Z-Leu-Leu-Nle-CHO) induces apoptosis of some tumor cells by inhibiting proteasome and Notch activity. Alterations in these two cell survival regulators contribute to apoptosis resistance of chronic lymphocytic leukemia (CLL) cells. Here, we investigated the mechanisms whereby GSI I increases apoptosis of primary CLL cells. Time-course studies indicate that initial apoptotic events are inhibition of proteasome activity, concomitant with an increased endoplasmic reticulum (ER) stress apoptotic signaling, and a consistent Noxa protein up-regulation. These events precede, and some of them contribute to, mitochondrial alterations, which occur notwithstanding Mcl-1 accumulation induced by GSI I. In CLL cells, GSI I inhibits Notch1 and Notch2 activation only in the late apoptotic phases, suggesting that this event does not initiate CLL cell apoptosis. However, Notch inhibition may contribute to amplify GSI I-induced CLL cell apoptosis, given that Notch activation sustains the survival of these cells, as demonstrated by the evidence that both Notch1 and Notch2 down-regulation by small-interfering RNA accelerates spontaneous CLL cell apoptosis. Overall, our results show that GSI I triggers CLL cell apoptosis by inhibiting proteasome activity and enhancing ER stress, and amplifies it by blocking Notch activation. These findings suggest the potential relevance of simultaneously targeting these three important apoptosis regulators as a novel therapeutic strategy for CLL.</p>
            </div>
      </section>
      <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
         <h2 id="d14195274" class="article-section__header short abstractlang_en short">Abstract</h2>
         <div class="article-section__content en short">
            <p><b>What's new?</b></p>
            <p>GSI-I is a γ-secretase inhibitor (GSI) that can induce apoptosis in some tumor cells. In this study of primary chronic lymphocytic leukemia (CLL) cells, the authors report that GSI I can increase apoptosis in apoptosis-resistant cells via three key cell-survival regulators: proteasome, endoplasmic reticulum (ER), and Notch. Given that several apoptotic pathways are dysregulated in CLL, this type of multi-targeted agent may prove to be more effective than highly selective drugs in blocking tumor-cell growth and survival. These findings may thus have important therapeutic implications.</p>
            </div>
      </section>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="below-abstract-group"><!-- Empty dropzone --></div>
   
   <section class="article-section article-section__full">
      <section class="article-section__content" id="sec1-bdy-1">
         
         <p>Chronic lymphocytic leukemia (CLL) is characterized by accumulation of malignant B CD5<sup>+</sup> cells, which are resistant to apoptosis.<span><a href="#bib1" class="bibLink tab-link" id="bib1R" data-tab="pane-pcw-references" aria-label="Reference 1 - N Engl J Med">1</a></span> Despite standard treatments and more recent targeted therapies,<span><a href="#bib2" class="bibLink tab-link" id="bib2R" data-tab="pane-pcw-references" aria-label="Reference 2 - Curr Hematol Malig Rep">2</a></span> CLL is still incurable. Given that in CLL, multiple pathways are dysregulated,<span><a href="#bib1" class="bibLink tab-link" id="bib1R" data-tab="pane-pcw-references" aria-label="Reference 1 - N Engl J Med">1</a></span> and considering that targeting one single pathway is often not sufficient to eliminate tumor cells,<span><a href="#bib4" class="bibLink tab-link" id="bib4R" data-tab="pane-pcw-references" aria-label="Reference 4 - Clin Cancer Res">4</a></span> it is necessary to develop novel strategies able to activate multiple apoptotic pathways and, simultaneously inhibit dysregulated survival pathways.</p>
         
         <p>γ-Secretase inhibitors (GSIs) include a wide range of small molecules proposed for therapy of malignancies driven by an aberrant Notch activity.<span><a href="#bib6" class="bibLink tab-link" id="bib6R" data-tab="pane-pcw-references" aria-label="Reference 6 - Oncogene">6</a></span> A dysregulated Notch signaling has been associated with the pathogenesis of several malignancies,<span><a href="#bib7" class="bibLink tab-link" id="bib7R" data-tab="pane-pcw-references" aria-label="Reference 7 - Blood">7</a></span> and GSIs have been shown to inhibit the growth and/or survival of several tumor cells,<span><a href="#bib8" class="bibLink tab-link" id="bib8R" data-tab="pane-pcw-references" aria-label="Reference 8 - Drug Resist Updat">8</a></span> including CLL cells.<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> Some GSIs have also been tested in phase I trials for patients with breast cancer<span><a href="#bib10" class="bibLink tab-link" id="bib10R" data-tab="pane-pcw-references" aria-label="Reference 10 - J Clin Oncol">10</a></span> and T-cell acute leukemias.<span><a href="#bib11" class="bibLink tab-link" id="bib11R" data-tab="pane-pcw-references" aria-label="Reference 11 - J Clin Oncol">11</a></span> However, in these malignancies, minimal clinical responses have been observed, and other studies have also suggested that Notch inhibition is therapeutically effective only when combined with inhibition of other relevant pathogenic pathways.<span><a href="#bib12" class="bibLink tab-link" id="bib12R" data-tab="pane-pcw-references" aria-label="Reference 12 - Nat Med">12</a>-<a href="#bib14" class="bibLink tab-link" id="bib14R" data-tab="pane-pcw-references" aria-label="Reference 14 - Br J Cancer">14</a></span> It has been recently shown that GSI I (Z-Leu-Leu-Nle-CHO), a tripeptide aldehyde inhibiting chymotryptic and aspartyl protease activity, chemically similar to the proteasome inhibitor MG132 (Z-Leu-Leu-Leu-CHO),<span><a href="#bib15" class="bibLink tab-link" id="bib15R" data-tab="pane-pcw-references" aria-label="Reference 15 - Development">15</a></span> induces apoptosis in breast<span><a href="#bib16" class="bibLink tab-link" id="bib16R" data-tab="pane-pcw-references" aria-label="Reference 16 - Br J Cancer">16</a></span> and glioblastoma tumor cells,<span><a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Mol Cancer Res">18</a></span> and in precursor-B acute lymphoblastic leukemia (ALL) cells<span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Leukemia">19</a></span> by inhibiting both γ-secretase and proteasome activity or only proteasome activity.<span><a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Breast Cancer Res">17</a></span> The ability of GSI I to target both Notch and proteasome can render it more effective in inducing antitumor activity in those tumor cells where dysregulated survival and/or growth are associated with alterations in both Notch signaling and proteasome activity. This might be also the case of CLL cells, given that both a constitutive Notch activation<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> and an up-regulated activity of ubiquitin-proteasome pathway<span><a href="#bib20" class="bibLink tab-link" id="bib20R" data-tab="pane-pcw-references" aria-label="Reference 20 - Blood">20</a></span> contribute to their apoptosis resistance. Furthermore, the evidence that in CLL, the clinical use of the highly specific proteasome inhibitor bortezomib has been associated with poor antitumor responses,<span><a href="#bib21" class="bibLink tab-link" id="bib21R" data-tab="pane-pcw-references" aria-label="Reference 21 - Cancer">21</a></span> suggests that the only inhibition of proteasome is not sufficient to kill CLL cells.</p>
         
         <p>One mechanism by which proteasome inhibitors mediate antitumor activity is that they prevent the clearance of misfolded proteins by the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway,<span><a href="#bib22" class="bibLink tab-link" id="bib22R" data-tab="pane-pcw-references" aria-label="Reference 22 - Proc Natl Acad Sci USA">22</a></span> resulting in protein accumulation in the ER and ER stress-induced apoptosis.<span><a href="#bib23" class="bibLink tab-link" id="bib23R" data-tab="pane-pcw-references" aria-label="Reference 23 - Cancer Biol Ther">23</a></span> Importantly, CLL cells have a functional ER stress-associated apoptotic signaling, and are susceptible to both pharmacologic and genetic ER targeting strategies.<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - Blood">24</a></span></p>
         
         <p>Based on all the above observations and our previous findings that GSI I increased CLL cell apoptosis and inhibited Notch activation,<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> we investigated whether an inhibited proteasome activity and an increased ER stress signaling are also involved in GSI I-induced CLL cell apoptosis, and examined how these events and Notch inhibition contribute to this apoptosis. Clarifying the effects of GSI I on these three critical regulators of CLL cell survival may be important to design more effective therapies for this leukemia. Results show that inhibition of proteasome activity, concomitant with an increased ER stress signaling and a consistent Noxa protein up-regulation, are critical initial events for GSI I-induced CLL cell apoptosis. After these effects, GSI I also inhibits Notch activation, event that contributes to amplify CLL cell apoptosis.</p>
         
         
         <h2 class="article-section__title section__title section1" id="block1-title"> <b>Abbreviations</b></h2>
         <p>ASK1: apoptosis signal-regulating kinase1; Bak: Bcl-2 homologous antagonist/killer; Bap 31: B-cell receptor-association protein 31; Bax: Bcl-2-associated X protein; Bcl-2: B-cell lymphoma protein-2; Bfl/A1: Bcl-2-related protein A1; BH3: Bcl-2 homology domain; Bim: Bcl-2 interacting mediator of cell death; CHOP/GADD153: C/EBP homologous protein/Growth Arrest and DNA Damage 153; CHX: cicloheximide; CLL: chronic lymphocytic leukemia; COX IV: cytochrome oxidase IV; DMSO: dimethyl sulfoxide; DSHB: Developmental Studies Hybridoma Bank; ER: endoplasmic reticulum; ERAD: ER-associated degradation; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; GSI: γ-secretase inhibitor; Hes1: hairy and enhancer of split 1; IRE1: inositol-requiring enzyme1; Mcl-1: myeloid cell leukemia-1; NICHD: National Institute of Child Health and Human Development; Omi/HtrA2: high temperature requirement serine protease A2; PARP: poly (ADP-ribose) polymerase; PI: propidium iodide; SAPK/JNK: stress-activated protein kinase/c-Jun N-terminal kinase; Smac/DIABLO: second mitochondria-derived activator of caspase/direct IAP binding protein with low pI; TRAF2: TNF receptor-associated factor2; ZAP-70: ζ-chain-associated protein-70; z-LEVD-fmk: Z-Leu-Glu (OMe)-Val-Asp (OMe)-fluoromethylketone; z-VAD-fmk: benzyloxycarbonyl-Val-Ala-Asp (OMe)-fluoromethylketone.</p>
         
         </section>
      <section class="article-section__content" id="sec1-1">
         
         <h2 class="article-section__title section__title section1" id="sec1-1-title"> Material and Methods</h2>
         
         <section class="article-section__sub-content" id="sec2-1">
            
            <h3 class="article-section__sub-title section2" id="sec2-1-title"> Patients</h3>
            
            <p>Twenty-two CLL patients entered this study. Diagnoses of CLL were performed according to the National Cancer Institute-sponsored Working Group guidelines,<span><a href="#bib26" class="bibLink tab-link" id="bib26R" data-tab="pane-pcw-references" aria-label="Reference 26 - Blood">26</a></span> and clinical staging was based on the Binet classification.<span><a href="#bib27" class="bibLink tab-link" id="bib27R" data-tab="pane-pcw-references" aria-label="Reference 27 - Cancer">27</a></span> This study was approved by the local Ethics Committee, and all patients signed informed consent in accordance with the Helsinki Declaration.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-2">
            
            <h3 class="article-section__sub-title section2" id="sec2-2-title"> Cell purification and culture</h3>
            
            <p>Peripheral blood mononuclear cells were isolated from heparinized blood of CLL patients by Ficoll density-gradient centrifugation (Nycomed, Oslo, Norway). Monocytes were removed by plastic adherence, and T cells by sheep erythrocyte rosetting. All CLL samples contained more than 96% CD19<sup>+</sup>/CD5<sup>+</sup> CLL cells, as assessed by flow cytometry (EPICS-XL-MCL; Beckman Coulter, Fullerton, CA).</p>
            
            <p>Freshly isolated CLL cells, resuspended at 2 × 10<sup>6</sup> cells/ml in complete medium consisting of RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT), 2 mM <span class="smallCaps">L</span>-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin (all from Invitrogen, Milan, Italy), were incubated in culture tubes (3 ml/tube) at 37°C in a 5% CO<sub>2</sub> atmosphere. The γ-secretase inhibitor I (GSI I; Z-Leu-Leu-Nle-CHO), the pan-caspase inhibitor z-VAD-fmk, the JNK inhibitor SP600125 (all from Calbiochem, La Jolla, CA), the caspase-4 inhibitor z-LEVD-fmk (BioVision, Mountain View, CA), and the translational inhibitor cycloheximide (CHX; Sigma-Aldrich, St. Louis, MO) were dissolved in dimethyl sulfoxide (DMSO) and diluted in complete medium at the used concentrations, which did not exceed 0.01% and did not affect CLL cell viability.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-3">
            
            <h3 class="article-section__sub-title section2" id="sec2-3-title"> CLL clinical laboratory characteristics</h3>
            
            <p>To investigate VDJ rearrangement, genomic DNA was amplified using a mixture of sense primers annealing to the V<sub>H</sub>1 through V<sub>H</sub>6 FR1 and anti-sense primers complementary to the germ line J<sub>H</sub> regions.<span><a href="#bib28" class="bibLink tab-link" id="bib28R" data-tab="pane-pcw-references" aria-label="Reference 28 - Leukemia">28</a></span> For somatic hypermutation analysis, PCR products were gel purified (Qiagen Gel Purification Kit; Qiagen, Milan, Italy) and directly sequenced by the automatic DNA sequencer ABI PRISM 3130 (Applied Biosystems, Warrington, UK). The National Center for Biotechnology Information (NCBI) Ig Blast database and sequence alignment tool was used to identify and compare sequences with the most homologous germline V<sub>H</sub> gene family. V<sub>H</sub> gene sequences deviating more than 2% from the corresponding germline gene were defined mutated. CD38 surface expression and ZAP-70 intracellular expression in CLL cells were examined as previously described.<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - Blood">24</a></span></p>
            
            <p>Supporting Information Table 1 gives clinical laboratory characteristics and the Binet stage of CLL patients.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-4">
            
            <h3 class="article-section__sub-title section2" id="sec2-4-title"> Mutation analysis of NOTCH1</h3>
            
            <p>The NOTCH1 exon 34 mutation previously identified in CLL<span><a href="#bib30" class="bibLink tab-link" id="bib30R" data-tab="pane-pcw-references" aria-label="Reference 30 - Br J Haematol">30</a></span> was analyzed by PCR amplification as described elsewhere<span><a href="#bib31" class="bibLink tab-link" id="bib31R" data-tab="pane-pcw-references" aria-label="Reference 31 - Science">31</a></span> and frequencies were determined using the NCBI database. Cycling conditions were: 95°C for 5 min (one cycle); 95°C for 45 sec; 58°C for 45 sec; 72°C for 1 min for 36 cycles; 72°C for 6 min (one cycle). After direct sequencing from both strands, purified amplicons were compared with corresponding germline sequences, and germline polymorphisms in the NCBI SNP database were excluded.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-5">
            
            <h3 class="article-section__sub-title section2" id="sec2-5-title"> OP9 coculture</h3>
            
            <p>OP9 bone marrow stromal cell line was maintained in IMDM containing 20% FBS, 10 mM Hepes, 1 mM sodium pyruvate, 1 mM <span class="smallCaps">L</span>-glutamine, 30 µM β-mercaptoethanol, 100 U/ml penicillin and 100 µg/ml streptomycin. One day before the experiment, OP9 cells were plated in 6-well plates (1 × 10<sup>5</sup>/well). Cocultures were initiated by seeding in each well, precoated with OP9, CLL cells resuspended at 3 × 10<sup>5</sup>/ml in complete medium (3 ml/well) containing GSI I. After 36 hr of coculture, CLL cells were removed from the monolayer. Contamining OP9 cells were eliminated filtering the harvested CLL cells through a 70-µm cell strainer (BD Falcon; Becton Dickinson, Bedford, MA). CLL cell purity was greater than 99%, as revealed by flow cytometric analysis of CD45 expression. Neither DMSO nor GSI I affected the OP9 monolayer integrity.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-6">
            
            <h3 class="article-section__sub-title section2" id="sec2-6-title"> MTS assay</h3>
            
            <p>The effect of GSI I on viability of OP9 cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay, using CellTiter 96 AQueous One Solution reagent (Promega, Madison, WI). OP9 cells were seeded in 96-well plates (5 × 10<sup>3</sup>/well), allowed to adhere for 1 day and then exposed to GSI I or DMSO as control. After 36-hr incubation, MTS reagent was added to the wells and after 2-hr incubation at 37°C, absorbance was measured in a plate reader at 490 nm.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-7">
            
            <h3 class="article-section__sub-title section2" id="sec2-7-title"> Apoptosis assay</h3>
            
            <p>Apoptosis was assessed by flow cytometric analysis (EPICS-XL-MCL) of Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI)-stained cells. Annexin V/PI assay was performed using a commercial kit (Immunotech; Beckman Coulter) according to the manufacturer's instructions.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-8">
            
            <h3 class="article-section__sub-title section2" id="sec2-8-title"> Western blot analysis</h3>
            
            <p>Whole-cell lysates and cytosolic and mitochondria-enriched fractions were prepared as previously described.<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - Blood">24</a></span> Equal amounts of proteins were separated by 7.5 to 15% SDS-PAGE and transferred to nitrocellulose membranes. Blots, after blocking, were incubated with primary antibodies to: caspase-4 (Medical & Biological Laboratories, Woburn, MA); cytochrome c (BD Biosciences, San Jose, CA); CHOP/GADD153, Bap31, Bax and Mcl-1 (Santa Cruz Biotechnology, Santa Cruz, CA); caspase-8, IRE1α, caspase-3, caspase-9, PARP, phospho-SAPK/JNK (Thr183/Tyr185) and total SAPK/JNK (Cell Signaling Technology, Beverly, MA); Smac/DIABLO (Upstate Biotechnology, Lake Placid, NY); Omi/HtrA2 (R&D Systems, Minneapolis, MN); cytochrome oxidase IV subunit II (COX IV; Invitrogen); Bim S/EL/L (Alexis Biochemicals, San Diego, CA); Noxa (Imgenex, San Diego, CA); Bcl-2 (DakoCytomation, Milan, Italy); GAPDH (Sigma-Aldrich); ubiquitinylated proteins (BIOMOL Research Laboratories, Plymouth Meeting, PA); Hes1 (Novus Biologicals, Littleton, CO); Notch1 (clone bTAN20) and Notch2 (clone C651.6DbHN), developed by Spiros Artavanis-Tsakonas, obtained from DSHB developed under the auspices of the NICHD, and maintained by Iowa University. Signals were detected using appropriate horseradish peroxidase-conjugated secondary antibodies and the ECL system (GE Healthcare, Milan, Italy). Densitometric analysis was performed using Quantity One software (Bio-Rad, Milan, Italy).</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-9">
            
            <h3 class="article-section__sub-title section2" id="sec2-9-title"> Real-time quantitative PCR</h3>
            
            <p>Total RNA was isolated using Trizol (Invitrogen) and 1 μg reverse-transcribed using RT-kit plus (Nanogen Advanced Diagnostics, Milan, Italy). Real-time quantitative PCR was performed with PCR Master Mix Power SYBR Green (Applied Biosystems), using the 7900HT Fast Real-Time PCR System (Applied Biosystems).</p>
            
            <p>The primer sequences used for NOXA were forward: 5′-GCTGGAAGTCGAGTGTGCTA-3′ and reverse: 5′-CCTGAGCAGAAGAGTTTGGA-3′ (Invitrogen). Relative fold change was normalized to GAPDH and calculated using the 2<sup>-ΔΔCt</sup> method.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-10">
            
            <h3 class="article-section__sub-title section2" id="sec2-10-title"> siRNA nucleofection</h3>
            
            <p>CLL cells (12 × 10<sup>6</sup>), resuspended in 100 μl Cell Line Solution Kit V (Lonza Group Ltd, Basel, Switzerland) with ON-TARGETplus SMARTpool siRNA to Mcl-1 (1 μM), Notch1 (0.5 μM), Notch2 (0.5 μM) or ON-TARGETplus siCONTROL nontargeting pool (Dharmacon RNA Technologies, Lafayette, CO), were transfected with the Amaxa Nucleofector II device (program U-013). In Mcl-1 experiments, cells were cultured for 24 hr in 12-well plates in complete medium. In Notch1 and Notch2 experiments, cells were cultured for 72 hr in 12-well plates in supernatants harvested from 48-hr cultures of OP9 cell line, to minimize spontaneous apoptosis of siControl transfected cells that could obscure the effect of Notch1 and Notch2 silencing.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-11">
            
            <h3 class="article-section__sub-title section2" id="sec2-11-title"> Statistical analysis</h3>
            
            <p>Statistical differences between mean values were evaluated using the Student's <i>t</i> test. The minimal level of significance was <i>p &lt;</i>0.05.</p>
            </section>
         </section>
      <section class="article-section__content" id="sec1-2">
         
         <h2 class="article-section__title section__title section1" id="sec1-2-title"> Results</h2>
         
         <section class="article-section__sub-content" id="sec2-12">
            
            <h3 class="article-section__sub-title section2" id="sec2-12-title"> GSI I increases apoptosis of CLL cells</h3>
            
            <p>CLL cells from 22 patients were exposed for 24 hr to increasing GSI I concentrations, and apoptosis was evaluated by Annexin V/PI staining. GSI I increased CLL cell apoptosis in a dose-dependent manner, with 0.1 µM which had a very marginal effect, 1 µM which increased apoptosis but not in a significant manner, and 2.5 and 5 µM which caused the highest effects (Supporting Information Figs. <a href="#fig1">S1</a><i>a</i> and S1<i>b</i>). GSI I induced apoptosis in CLL cells from all examined patients, regardless of clinical stage and biological characteristics. NOTCH1 mutational status of CLL samples does not seem to affect the susceptibility of CLL cells to GSI I-induced apoptosis. Indeed, the NOTCH1 PEST domain mutation (c.7544_7545delCT) previously identified in CLL,<span><a href="#bib30" class="bibLink tab-link" id="bib30R" data-tab="pane-pcw-references" aria-label="Reference 30 - Br J Haematol">30</a></span> occurred in 2 of the 22 examined patients (3 and 14), and in these two samples, reduction of cell viability by GSI I was similar in extent to that observed in unmutated samples (Supporting Information Table 2).</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig1"><a target="_blank" href="/cms/asset/fd7e671d-7546-411c-a3c8-439e3100628b/mfig001.jpg"><picture>
                        <source srcset="/cms/asset/fd7e671d-7546-411c-a3c8-439e3100628b/mfig001.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/05edb69d-768f-4594-b82c-53b0475588d7/mfig001.jpg" data-lg-src="/cms/asset/fd7e671d-7546-411c-a3c8-439e3100628b/mfig001.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 1</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig1&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Effect of GSI I on CLL cell apoptosis. (<i>a</i> and <i>b</i>) GSI I increases CLL cell apoptosis in a time-dependent manner. Freshly isolated CLL cells (<i>n =</i>12) were exposed for the indicated times to 2.5 µM GSI I or 0.005% DMSO. (<i>c</i>) GSI I decreases CLL cell viability in the presence of OP9 bone marrow stromal cells. Freshly isolated CLL cells (<i>n</i> = 6) were cultured for 36 hr in the absence or on an OP9 monolayer, with or without the indicated doses of GSI I as described in “OP9 coculture”. (<i>a-c</i>) Cell viability and apoptosis were evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining. (<i>a</i> and <i>b</i>) Results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>), early apoptotic (An V<sup>+</sup>/PI<sup>−</sup>), late apoptotic (An V<sup>+</sup>/PI<sup>+</sup>), and necrotic (An V<sup>−</sup>/PI<sup>+</sup>) cells. (<i>a</i>) Results are the mean ± SD of 12 patients. **<i>p</i> &lt; 0.01 (An V<sup>−</sup>/PI<sup>−</sup>) cells in GSI I <i>vs.</i> An V<sup>−</sup>/PI<sup>−</sup> cells in DMSO at each time-point) according to Student's <i>t</i> test. (<i>b</i>) Results shown for patient 2 are representative of 12 patients. (<i>c</i>) Results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>) cells and are the mean ± SD of six patients. **<i>p</i> &lt; 0.01 (cells cultured with OP9 and each dose of GSI I <i>vs.</i> cells cultured with OP9 alone) according to Student's <i>t</i> test. (<i>d</i>) Effect of GSI I on OP9 cell viability. Viability of OP9 cells treated for 36 hr with the indicated doses of GSI I or 0.01% DMSO as control was measured by MTS assay. Results are presented as optical density (OD) values and are the mean ± SD of four experiments performed in triplicate.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            
            <p>We then determined the time-course of GSI I-induced apoptosis. In these and several of the next time-course experiments, CLL cells from 12 samples (1–12), including patients with different characteristics, were exposed to 2.5 µM GSI I for 1, 4, 8 and 24 hr. GSI I, after 1 hr, had a marginal effect on CLL cell apoptosis, which began to increase after 4 hr and progressively increased up to 24 hr (Figs. <a href="#fig1">1</a><i>a</i> and <a href="#fig1">1</a><i>b</i>).</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-13">
            
            <h3 class="article-section__sub-title section2" id="sec2-13-title"> GSI I increases CLL cell apoptosis in the presence of bone marrow stromal support</h3>
            
            <p>Since bone marrow microenvironment provides survival advantage and confers chemoresistance to CLL cells,<span><a href="#bib32" class="bibLink tab-link" id="bib32R" data-tab="pane-pcw-references" aria-label="Reference 32 - Blood">32</a></span> we investigated whether GSI I is able to induce CLL cell apoptosis in the presence of OP9 bone marrow stromal cells. We cocultured CLL cells for 36 hr with OP9 cells with or without GSI I, and evaluated CLL cell viability and apoptosis by Annexin V/PI staining. We performed these experiments in CLL cells from six samples (2–7), selected to include patients with different characteristics. Results show that GSI I, at both 2.5 and 5 µM, decreased CLL cell viability also in the presence of OP9 cells, although they triggered pro-survival signals to CLL cells (Fig. <a href="#fig1">1</a><i>c</i>). To exclude that GSI I overcomes the pro-survival effect of OP9 cells on CLL cells because of a direct toxicity on stromal support, we examined the effect of GSI I on OP9 cell viability using MTS assay. Results show that OP9 cell viability was not affected by GSI I, either at 2.5 or 5 µM (Fig. <a href="#fig1">1</a><i>d</i>).</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-14">
            
            <h3 class="article-section__sub-title section2" id="sec2-14-title"> GSI I rapidly inhibits proteasome activity in CLL cells</h3>
            
            <p>To investigate whether GSI I inhibits proteasome activity in CLL cells, we analyzed (patients 1–12) the accumulation of polyubiquitinated proteins, which is an indicator of proteasome inhibition and a cause of proteasome inhibitor-induced apoptosis.<span><a href="#bib33" class="bibLink tab-link" id="bib33R" data-tab="pane-pcw-references" aria-label="Reference 33 - Drug Resist Updat">33</a></span> Time-course analysis shows that GSI I, already after 1 hr, induced, compared with controls, a strong accumulation of polyubiquitinated proteins, which further increased at 4 and 8 hr and to a lesser degree at 24 hr (Fig. <a href="#fig2">2</a><i>a</i>). These results show that GSI I rapidly inhibits proteasome activity in CLL cells, and suggest that proteasome inhibition may be one of the initial triggering events for GSI I-induced CLL cell apoptosis.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig2"><a target="_blank" href="/cms/asset/c8369099-b5c3-4738-9ba0-ddefeb85bdbb/mfig002.jpg"><picture>
                        <source srcset="/cms/asset/c8369099-b5c3-4738-9ba0-ddefeb85bdbb/mfig002.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/eb3f7ce7-a2dc-482a-80b4-c5f28e239e38/mfig002.jpg" data-lg-src="/cms/asset/c8369099-b5c3-4738-9ba0-ddefeb85bdbb/mfig002.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 2</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig2&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>GSI I increases accumulation of polyubiquitinated proteins and ER stress apoptotic signaling in CLL cells. (<i>a-c</i>) Time-course of GSI I effects on accumulation of polyubiquitinated proteins, proteolytic processing of caspase-4, -8, and -3, degradation of PARP, and expression and activation of markers associated with ER stress apoptosis. Western blot analysis was performed in 20 µg whole-cell lysates extracted from CLL cells exposed for the indicated times to 2.5 µM GSI I or 0.005% DMSO as control (<i>n</i> = 12). Protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. (<i>b</i>, <i>left panel</i>) In caspase blots, separated panels are shown because long X-ray film exposure was necessary to detect the active subunits. The asterisk in caspase-4 blot indicates bands derived from unknown cleavage. The density of the bands corresponding to the active subunit (20-kDa) of caspase-4 (<i>b, right panel</i>) and to CHOP (<i>c, right panel</i>) was evaluated by densitometric analysis. Densitometry units (U) were calculated relative to GAPDH. Results shown for patients 2 and 3 (<i>a</i>) and patient 2 (<i>b</i> and <i>c, left panels</i>) are representative of 12 patients. (<i>b</i> and <i>c, right panels</i>) Results are the mean ± SD of 12 patients. (<i>b, right panel</i>) *<i>p</i> &lt; 0.05, **<i>p</i> &lt; 0.01 (GSI I <i>vs</i>. DMSO at each time-point) according to Student's <i>t</i> test. (<i>c, right panel</i>) The differences between GSI I and DMSO are not significant at any time-point.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-15">
            
            <h3 class="article-section__sub-title section2" id="sec2-15-title"> GSI I rapidly increases apoptotic ER stress signaling in CLL cells</h3>
            
            <p>Based on our recent findings that <i>ex vivo</i> CLL cells have a functional ER stress-triggered caspase cascade initiated by caspase-4 and involving caspase-8 and -3,<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - Blood">24</a></span> we first investigated whether GSI I potentiates the activation of these caspases (patients 1–12). Time-course analysis shows that the cleavage of caspase-4 into its active 20-kDa subunit was increased by GSI I, compared with controls, already after 1 hr and continued to be increased until 24 hr (Fig. <a href="#fig2">2</a><i>b</i>). GSI I also enhanced caspase-8 and -3 activation and PARP degradation, with effects evident from 4 hr onward (Fig. <a href="#fig2">2</a><i>b</i>). To examine the role of caspase-4 and the overall contribution of caspases to GSI I-induced apoptosis, we examined the effect of the caspase-4 inhibitor z-LEVD-fmk and the pan-caspase inhibitor z-VAD-fmk on the viability and apoptosis of CLL cells treated with GSI I (patients 2–7). Results show that the decrease of cell viability induced by GSI I compared with controls, was partially prevented by z-LEVD-fmk and completely prevented by z-VAD-fmk (Supporting Information Fig. <a href="#fig2">S2</a><i>a</i>). Caspase-4 inhibitor z-LEVD-fmk also reduced the GSI I-induced processing of caspase-8 and -3 to their active 18- and 17-kDa subunits, respectively (Supporting Information Fig. <a href="#fig2">S2</a><i>b</i>), suggesting that GSI I-induced caspase-4 activation acts upstream of caspase-8 and -3.</p>
            
            <p>We next examined the effect of GSI I on other proapoptotic events associated with ER stress, including the expression of the transcription factor CHOP/GADD153,<span><a href="#bib34" class="bibLink tab-link" id="bib34R" data-tab="pane-pcw-references" aria-label="Reference 34 - Cell Death Differ">34</a></span> the cleavage of the ER membrane protein Bap31 into the proapoptotic ER membrane-embedded fragment Bap20, event known to be induced by caspase-8 and important in propagating apoptotic signals from ER to mitochondria,<span><a href="#bib35" class="bibLink tab-link" id="bib35R" data-tab="pane-pcw-references" aria-label="Reference 35 - J Cell Biol">35</a></span> and the phosphorylation of JNK1/2, a kinase activated by the IRE1-TRAF2-ASK1 branch of the ER stress response,<span><a href="#bib36" class="bibLink tab-link" id="bib36R" data-tab="pane-pcw-references" aria-label="Reference 36 - Science">36</a></span> and involved in connecting ER to mitochondria<span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - J Bioenerg Biomembr">37</a></span> (patients 1–12). Results show that CHOP/GADD153 levels, which in controls increased from 1 hr onward, were not further increased by GSI I, whereas Bap31 cleavage into Bap20, which also progressively increased in controls, was further enhanced by GSI I, with evident effects observed at 8 and 24 hr (Fig. <a href="#fig2">2</a><i>c</i>). JNK1/2 phosphorylation was also enhanced by GSI I from 1 up to 8 hr and decreased at 24 hr, however, remaining higher than in controls, where it had almost completely decreased (Fig. <a href="#fig2">2</a><i>c</i>). IRE1α expression, which in controls, increased from 1 hr onward, was further enhanced by GSI I after 1 and 4 hr and decreased at later time-points (Fig. <a href="#fig2">2</a><i>c</i>). Altogether, these results show that GSI I increases CLL cell apoptosis activating several pathways associated with ER stress.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-16">
            
            <h3 class="article-section__sub-title section2" id="sec2-16-title"> GSI I increases the activation of the mitochondrial apoptotic pathway in CLL cells</h3>
            
            <p>To determine whether mitochondrial alterations are involved in GSI I-induced CLL cell apoptosis, we examined, in CLL cells exposed to GSI I, the time-course of cytochrome c, Smac/DIABLO and Omi/HtrA2 release from the mitochondria to the cytosol (patients 1–12). In all examined samples, the cytosolic levels of all three proteins began to increase at 4 hr following treatment compared with controls, and progressively increased up to 24 hr. A concomitant reduction in mitochondrial levels of all three proteins, compared with controls, began to appear after 8 hr of treatment, and was more pronounced at 24 hr (Fig. <a href="#fig3">3</a><i>a</i>). Proteolytic activation of caspase-9, known to initiate the cytochrome c-dependent caspase cascade, also began to increase after 4 hr of treatment compared with controls, continued to increase at 8 hr and returned to control values at 24 hr (Fig. <a href="#fig3">3</a><i>b</i>). Altogether, these results show that GSI I increases the mitochondrial pathway activation, and that this event occurs after proteasome inhibition and ER stress induction.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig3"><a target="_blank" href="/cms/asset/0cd09a66-1a90-49c7-99f3-4666e998355f/mfig003.jpg"><picture>
                        <source srcset="/cms/asset/0cd09a66-1a90-49c7-99f3-4666e998355f/mfig003.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/1eba96db-3587-4d28-a517-98a40ac7c6a5/mfig003.jpg" data-lg-src="/cms/asset/0cd09a66-1a90-49c7-99f3-4666e998355f/mfig003.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 3</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig3&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>GSI I increases the activation of the mitochondrial apoptotic pathway in CLL cells. (<i>a</i> and <i>b</i>) Time-course analysis of mitochondrial apoptogenic protein release into the cytosol and caspase-9 processing during GSI I-induced CLL cell apoptosis. Freshly isolated CLL cells (<i>n =</i>12) were exposed for the indicated times to 2.5 µM GSI I or 0.005% DMSO as control. (<i>a</i>) The levels of cytochrome c, Smac/DIABLO and Omi/HtrA2 were analyzed by western blot in cytosol and mitochondria-enriched fraction (MF) extracts (20 µg). The blots were reprobed with an anti-COX IV antibody to control the purity of cytosolic fraction and the loading of MF, and with an anti-GAPDH antibody to control the loading of cytosolic extracts. Data shown for patient 2 are representative of 12 patients. (<i>b</i>) Caspase-9 processing was analyzed by western blot in 20 µg whole-cell lysates, and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. The density of the bands corresponding to the active subunits of caspase-9 (35- and 37-kDa) was evaluated by densitometric analysis. Densitometry units (U) were calculated relative to GAPDH. Data shown for patient 2 are representative of 12 patients. (<i>c-e</i>) Effect of pharmacologic JNK1/2 inhibition on mitochondrial apoptogenic protein release and CLL cell apoptosis induced by GSI I. Freshly isolated CLL cells (<i>n</i> = 6) were pretreated for 30 min with 20 µM of the JNK1/2 inhibitor SP600125 or 0.005% DMSO as control, and then exposed for further 16 hr to 2.5 µM GSI I. (<i>c</i>) Phosphorylation and expression of JNK1/2 were analyzed by western blot in 20 µg whole-cell lysates, and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. (<i>d</i>) The levels of cytochrome c and Smac/DIABLO were analyzed in 20 µg cytosolic lysates as described in (<i>a</i>). The density of the bands corresponding to cytochrome c and Smac/DIABLO was evaluated by densitometric analysis. Densitometry units (U) were calculated relative to GAPDH. (<i>c</i> and <i>d</i>) Data shown for patient 2 are representative of six patients. (<i>e</i>) Cell viability and apoptosis were evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining. Results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>) cells and are the mean ± SD of six patients. *<i>p</i> &lt; 0.05 (cells treated with SP600125 and GSI I <i>vs.</i> cells treated with GSI I) according to Student's <i>t</i> test.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-17">
            
            <h3 class="article-section__sub-title section2" id="sec2-17-title"> JNK1/2 signaling activated by GSI I is involved in converging ER stress apoptotic signals to the mitochondria.</h3>
            
            <p>It is known that JNK1/2 activation connects ER stress with mitochondrial apoptosis by several mechanisms.<span><a href="#bib37" class="bibLink tab-link" id="bib37R" data-tab="pane-pcw-references" aria-label="Reference 37 - J Bioenerg Biomembr">37</a></span> To determine whether the increased JNK1/2 phosphorylation induced by GSI I contributes to mitochondrial alterations, we analyzed the effect of the JNK inhibitor SP600125 on cytochrome c and Smac/DIABLO release to the cytosol, induced by GSI I in CLL cells (patients 2–7). In all examined samples, SP600125 completely abrogated the increase in JNK1/2 phosphorylation induced by GSI I (Fig. <a href="#fig3">3</a><i>c</i>) and partially prevented the cytosolic accumulation of cytochrome c and Smac/DIABLO (Fig. <a href="#fig3">3</a><i>d</i>), as well as the decrease of CLL cell viability induced by GSI I (Fig. <a href="#fig3">3</a><i>e</i>). These results suggest that JNK1/2 activation by GSI I contributes, at least in part, to CLL cell apoptosis by converging ER stress apoptotic signals to the mitochondria.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-18">
            
            <h3 class="article-section__sub-title section2" id="sec2-18-title"> GSI I-induced apoptosis of CLL cells is associated with Noxa up-regulation and occurs notwithstanding Mcl-1 accumulation</h3>
            
            <p>Having shown that, in CLL cells, GSI I activates the mitochondrial apoptotic pathway, and given the crucial role of Bcl-2 family members in controlling mitochondrial apoptosis,<span><a href="#bib38" class="bibLink tab-link" id="bib38R" data-tab="pane-pcw-references" aria-label="Reference 38 - Nat Cell Biol">38</a></span> we investigated the effect of GSI I on some of these molecules (patients 1–12). Analysis of the antiapoptotic proteins Bcl-2 and Mcl-1, critical mediators of CLL cell survival,<span><a href="#bib39" class="bibLink tab-link" id="bib39R" data-tab="pane-pcw-references" aria-label="Reference 39 - Immunology">39</a></span> showed that whereas Bcl-2 expression remained unchanged after GSI I treatment, Mcl-1 levels were rapidly increased, compared with controls, already after 1 hr. Mcl-1 levels were maintained high by GSI I up to 24 hr, time at which, in control cells, they were reduced (Fig. <a href="#fig4">4</a><i>a</i>). We next examined the proapoptotic proteins Bax, known to directly affect the outer mitochondrial membrane permeability to apoptogenic factors, and the BH3-only proteins Noxa and Bim, which function, the former, by neutralizing the antiapoptotic Mcl-1 and Bfl/A1 thereby releasing Bax and Bak, and the latter, by directly inducing Bax oligomerization.<span><a href="#bib38" class="bibLink tab-link" id="bib38R" data-tab="pane-pcw-references" aria-label="Reference 38 - Nat Cell Biol">38</a></span> Analysis of cytosolic and mitochondria-enriched fractions revealed that GSI I, from 4 hr onward, induced a time-dependent reduction of cytosolic Bax levels accompanied by an increase in the mitochondrial levels (Fig. <a href="#fig4">4</a><i>b</i>). Analysis of Noxa and Bim proteins showed that Noxa levels were strongly up-regulated, as early as 1 hr following treatment, and continued to increase with time (Figs. <a href="#fig4">4</a><i>c</i>
               <i>left panel</i> and 4<i>d</i>), whereas Bim EL, L and S isoform levels remained unchanged after GSI I treatment (Fig. <a href="#fig4">4</a><i>c</i>
               <i>right panel</i>). This high Noxa expression suggests that it is a critical effector in GSI I-induced CLL cell apoptosis and prompted us to examine whether Noxa increase was due to transcriptional up-regulation (patients 2-7). GSI I induced, already after 1 hr, a weak increase in Noxa mRNA levels which progressively increased with time, exceeding, after 24 hr, a ninefold increase compared with untreated cells (Fig. <a href="#fig4">4</a><i>e</i>). Therefore, GSI I, especially in the late phases of apoptosis, up-regulates Noxa protein by increasing its transcription. Noxa up-regulation by GSI I also depends on protein synthesis, given that treating CLL cells with GSI I in the presence of the translation inhibitor CHX (patients 2–7) strongly prevented GSI I-induced Noxa increase (Fig. <a href="#fig4">4</a><i>f</i>). These results along with the evidence that CHX prevented the decrease of CLL cell viability induced by GSI I (Fig. 4<i>g</i>) suggest that GSI I-induced CLL cell apoptosis requires the synthesis of proapoptotic protein(s), including Noxa.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig4"><a target="_blank" href="/cms/asset/20e6536d-3100-4e43-b011-e27a5d13bcc8/mfig004.jpg"><picture>
                        <source srcset="/cms/asset/20e6536d-3100-4e43-b011-e27a5d13bcc8/mfig004.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/baf801b8-efd7-4d73-b75c-89d868d3e676/mfig004.jpg" data-lg-src="/cms/asset/20e6536d-3100-4e43-b011-e27a5d13bcc8/mfig004.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 4</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig4&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Effect of GSI I on Bcl-2 family members in CLL cells. (<i>a, c</i> and <i>d</i>) Time-course analysis of Bcl-2, Mcl-1, Noxa and Bim (EL, L and S isoforms) expression. Western blot analysis was performed in 20 µg whole-cell lysates isolated from CLL cells (<i>n</i> = 12) exposed for the indicated times to 2.5 µM GSI I or 0.005% DMSO as control. Bcl-2, Mcl-1 (<i>a</i>) and Noxa (<i>c, left panel</i>) expression was analyzed using the same filter, and protein loading was assessed reprobing the blot with an anti-GAPDH antibody. Data shown for patient 2 are representative of 12 patients. (<i>d</i>) The blots of Noxa were subjected to densitometry analysis and densitometry units (U) were calculated relative to GAPDH. Results are the mean ± SD of 12 patients. *<i>p</i> &lt; 0.05 (GSI I <i>vs</i>. DMSO at each time-point) according to Student's <i>t</i> test. (<i>b</i>) Time-course analysis of Bax release from the mitochondria. Western blot analysis was performed in 20 µg of cytosol and mitochondria-enriched fraction (MF) extracted from CLL cells (<i>n</i> = 12) treated as in (<i>a</i>). The blots were reprobed with an anti-COX IV antibody to control the purity of cytosolic fraction and the loading of MF, and with an anti-GAPDH antibody to control the loading of cytosolic extracts. Data shown for patient 2 are representative of 12 patients. (<i>e</i>) Time-course analysis of Noxa mRNA expression. Noxa mRNA levels were evaluated by real-time PCR in CLL cells before (Time 0) and after the indicated times of culture (<i>n</i> = 6). Noxa mRNA levels were normalized to GAPDH and represented as fold change with respect to levels in CLL cells at time 0. Results are the mean ± SD of six patients. **<i>p</i> &lt; 0.01 (GSI I <i>vs</i>. DMSO at each time-point) according to Student's <i>t</i> test. (<i>f</i> and <i>g</i>). Effect of the translational inhibitor CHX on GSI I-induced Noxa protein expression and CLL cell apoptosis. CLL cells (<i>n</i> = 6) were treated for 12 hr with 2.5 µM GSI I in the presence of 1 µg/ml CHX. (<i>f</i>) Western blot analysis of Noxa was performed as described in (<i>c</i>). Vertical lines inserted in the blots indicate a repositioned gel lane. Data shown for patient 2 are representative of six patients. (<i>g</i>) Cell viability and apoptosis were evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining. Results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>) cells and are the mean ± SD of six patients. **<i>p</i> &lt; 0.01 (cells treated with CHX and GSI I <i>vs.</i> cells treated with GSI I) according to Student's <i>t</i> test. (<i>h)</i> Effect of the JNK inhibitor SP600125 on GSI I-induced Noxa protein expression. Western blot analysis of JNK1/2 phosphorylation and Noxa expression was performed in 20 µg whole-cell lysates isolated from CLL cells pretreated for 30 min with 20 µM SP600125 and then exposed to 2.5 µM GSI I for 12 hr (<i>n</i> = 6). Protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. Vertical lines inserted in the blots indicate a repositioned gel lane. The blots of Noxa were subjected to densitometry analysis and densitometry units (U) were calculated relative to GAPDH. Data shown for patient 2 are representative of six patients.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            
            <p>Next, in an attempt to discover the mechanisms implicated in Noxa up-regulation by GSI I, we investigated the possible involvement of JNK1/2 signaling. Noxa protein expression was analyzed in CLL cells pretreated with the JNK inhibitor SP600125 and then exposed to GSI I (patients 2–7). In all examined samples, inhibition of JNK1/2 phosphorylation induced by SP600125 (Fig. 4<i>h</i>
               <i>left panel</i>) resulted in decreased Noxa expression (Fig. 4<i>h</i>
               <i>right panel</i>), and suggests that JNK signaling contributes, at least in part, to Noxa protein up-regulation by GSI I, thus further contributing to mitochondrial pathway activation.</p>
            </section>
         
         <section class="article-section__sub-content" id="sec2-19">
            
            <h3 class="article-section__sub-title section2" id="sec2-19-title"> Silencing of Mcl-1 enhances apoptotic activity of GSI I in CLL cells</h3>
            
            <p>Having shown that GSI I rapidly induced accumulation of Mcl-1 protein, a critical factor for CLL cell survival and chemoresistance,<span><a href="#bib40" class="bibLink tab-link" id="bib40R" data-tab="pane-pcw-references" aria-label="Reference 40 - Blood">40</a></span> we investigated whether Mcl-1 accumulation affects proapoptotic activity of GSI I. Therefore, we examined the effect of Mcl-1 down-regulation by siRNA on GSI I-induced CLL cell apoptosis. CLL cells were transfected with control nontargeting (siCtrl) or Mcl-1 siRNA (siMcl-1), and 24 hr after transfection were exposed for 4 hr to 2.5 µM GSI I or DMSO. We performed these experiments in CLL cells from five samples, including patients with different characteristics (2, 13–16). Western blot analysis performed after transfection showed that, in siMcl-1 CLL cells of the different patients, there was a significant reduction of Mcl-1 (Fig. <a href="#fig5">5</a><i>a</i>) which, consistent with previous studies,<span><a href="#bib41" class="bibLink tab-link" id="bib41R" data-tab="pane-pcw-references" aria-label="Reference 41 - Blood">41</a></span> resulted in decreased CLL cell viability, as indicated by increased PARP degradation (Fig. <a href="#fig5">5</a><i>a</i>) and reduced percentage of viable Annexin V<sup>−</sup>/PI<sup>−</sup> cells (Fig. <a href="#fig5">5</a><i>b</i>). When transfected CLL cells were exposed to GSI I or DMSO, we found that in siCtrl cells treated with GSI I, there was a substantial accumulation of Mcl-1 which reached high expression levels, whereas in siMcl-1 cells, Mcl-1 levels remained low in response to GSI I, even if in some patients, they increased compared with siMcl-1 cells in DMSO (Figs. <a href="#fig5">5</a><i>c</i> and <a href="#fig5">5</a><i>d</i>). Analysis of Annexin V/PI staining shows that whereas in siCtrl cells, GSI I decreased cell viability by only 19.9 ± 7.2% (<i>p</i> &lt; 0.01) compared with DMSO, in siMcl-1 CLL cells, GSI I decreased cell viability by 64.5 ± 10.2% (<i>p</i> &lt; 0.01) (Figs. <a href="#fig5">5</a><i>e</i> and <a href="#fig5">5</a><i>f</i>). These data show that Mcl-1 down-regulation enhances GSI I-induced CLL cell apoptosis suggesting that Mcl-1 accumulation induced by GSI I may slow down, but does not impede, mitochondrial pathway activation.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig5"><a target="_blank" href="/cms/asset/4f779ad1-32fe-49a5-848a-e942efc6edd5/mfig005.jpg"><picture>
                        <source srcset="/cms/asset/4f779ad1-32fe-49a5-848a-e942efc6edd5/mfig005.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/1b21d180-be07-4570-8f46-c721fb3b1e05/mfig005.jpg" data-lg-src="/cms/asset/4f779ad1-32fe-49a5-848a-e942efc6edd5/mfig005.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 5</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig5&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Effect of Mcl-1 down-regulation on GSI I-induced apoptosis of CLL cells. (<i>a</i> and <i>b</i>) Freshly isolated CLL cells (<i>n</i> = 5) were transfected with 1 µM of control nontargeting (siCtrl) or Mcl-1 siRNA (siMcl-1) as described in “siRNA nucleofection” and then cultured in complete medium for 24 hr. (<i>a</i>) Mcl-1 expression and PARP degradation were analyzed by western blot in 20 µg whole-cell lysates, and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. (<i>b</i>) Cell viability and apoptosis were evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining and results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>), early apoptotic (An V<sup>+</sup>/PI<sup>−</sup>), late apoptotic (An V<sup>+</sup>/PI<sup>+</sup>), and necrotic (An V<sup>−</sup>/PI<sup>+</sup>) cells. (<i>a</i> and <i>b</i>) Results shown for patients 2, 13 and 16 are representative of 5 patients. (<i>c-f</i>) After transfection, siCtrl or siMcl-1 CLL cells were exposed for 4 hr to 2.5 µM GSI I or 0.005% DMSO. (<i>c</i> and <i>d</i>) Mcl-1 expression was determined as described in (<i>a</i>). Blots of each sample were subjected to densitometric analysis and densitometry units (U) were calculated relative to GAPDH. In panel <i>c</i>, data of patients 2, 13 and 16 are representative of five patients. (<i>d</i>) Data are the mean ± SD of five patients. *<i>p</i> &lt; 0.05 (GSI-treated <i>vs</i>. DMSO-treated for each transfection condition) according to Student's <i>t</i> test. (<i>e</i> and <i>f</i>) Cell viability was evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining and data are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>) cells. (<i>e</i>) Data of patients 2, 13 and 16 are representative of five patients. (<i>f</i>) Data are the mean ± SD of five patients. **<i>p</i> &lt; 0.01 (GSI-treated <i>vs.</i> DMSO-treated for each transfection condition) according to Student's <i>t</i> test.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         
         <section class="article-section__sub-content" id="sec2-20">
            
            <h3 class="article-section__sub-title section2" id="sec2-20-title"> Notch inhibition by GSI I contributes to amplify CLL cell apoptosis</h3>
            
            <p>During previous studies involving Notch in CLL cell survival, we found that GSI I, after 24 hr, increased CLL cell apoptosis and inhibited Notch signaling.<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> Here, to define how this event contributes to GSI I-induced CLL cell apoptosis, we first examined the time-course effect of GSI I on Notch1 and Notch2 processing and Hes1 protein expression, a target of Notch2 in CLL cells.<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> We performed these experiments in CLL cells from 12 samples (2–7, 17–22), including patients with different characteristics. In all samples, GSI I inhibited the generation of Notch1 and Notch2 intracellular domains (IC), as well as the expression of the precursors (P) and the transmembrane/cytoplasmic portion (TM), only after 24 hr, whereas up to 8 hr, the levels of the three forms of both receptors appeared slightly increased or unchanged compared with controls (Fig. <a href="#fig6">6</a><i>a</i>). Hes1 expression was also reduced by GSI I after 24 hr, whereas up to 8 hr, Hes1 levels appeared stable (Fig. <a href="#fig6">6</a><i>b</i>). The evidence that GSI I inhibits Notch signaling at the time of maximum CLL cell apoptosis indicates that Notch inhibition is not critical for initiating apoptosis. However, this event contributes to amplify CLL cell apoptosis, because Notch signaling has a pro-survival role in these cells. This was demonstrated in genetic inhibition studies, in which Notch1 and Notch2 were down-regulated by siRNA (patients 2, 18–22). Results show that siRNA down-regulation of both Notch1, as demonstrated for the first time here (Figs. <a href="#fig6">6</a><i>c</i> and <a href="#fig6">6</a><i>d</i>), and Notch2, as previously reported<span><a href="#bib9" class="bibLink tab-link" id="bib9R" data-tab="pane-pcw-references" aria-label="Reference 9 - Blood">9</a></span> and shown in Supporting Information Figures <a href="#fig3">S3</a><i>a</i> and S3<i>b</i>, increased CLL cell apoptosis compared with siCtrl treatment.</p>
            
            <section class="article-section__inline-figure">
               <figure class="figure" id="fig6"><a target="_blank" href="/cms/asset/d3d13ea8-254f-4afd-b735-1b215dbbd381/mfig006.jpg"><picture>
                        <source srcset="/cms/asset/d3d13ea8-254f-4afd-b735-1b215dbbd381/mfig006.jpg" media="(min-width: 1650px)"></source><img class="figure__image" src="/cms/asset/fd64cf11-1dd5-40c7-96ee-8dbf6939144c/mfig006.jpg" data-lg-src="/cms/asset/d3d13ea8-254f-4afd-b735-1b215dbbd381/mfig006.jpg" alt="Details are in the caption following the image" loading="lazy"></picture></a><figcaption class="figure__caption">
                     <div class="figure__caption__header"><strong class="figure__title">Figure 6</strong><div class="figure-extra"><a href="#" class="open-figure-link">Open in figure viewer</a><a href="/action/downloadFigures?id=fig6&amp;doi=10.1002%2Fijc.27863" class="ppt-figure-link"><i aria-hidden="true" class="icon-Icon_Download"></i><span>PowerPoint</span></a></div>
                     </div>
                     <div class="figure__caption figure__caption-text">
                        <p>Contribution of Notch inhibition by GSI I to CLL cell apoptosis. (<i>a</i> and <i>b</i>) Time-course analysis of the effect of GSI I on Notch1 and Notch2 activation. Freshly isolated CLL cells (<i>n</i> = 12) were cultured for the indicated times in complete medium with 2.5 µM GSI I or 0.005% DMSO as control. Western blot analysis of Notch1, Notch2 and Hes1 was performed on whole-cell lysates (10 µg for Notch receptors and 40 µg for Hes1), and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. In Notch1 and Notch2 blots, separated panels are shown because long X-ray film exposure was necessary to detect the precursors (P). Data of patients 2 and 18 are representative of 12 patients. (<i>c</i> and <i>d</i>) Effect of specific Notch1 down-regulation on CLL cell apoptosis. Freshly isolated CLL cells (<i>n</i> = 6) were transfected with 0.5 µM of control nontargeting (siCtrl) or Notch1 siRNA as described in “siRNA nucleofection” and then cultured for 72 hr in supernatants harvested from 48-hr cultures of OP9 cell line. (<i>c</i>) Western blot analysis of Notch1 was performed as described in (<i>a</i>). (<i>d</i>) Apoptosis was evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining. Results are presented as the percentage of viable (An V<sup>−</sup>/PI<sup>−</sup>), early apoptotic (An V<sup>+</sup>/PI<sup>−</sup>), late apoptotic (An V<sup>+</sup>/PI<sup>+</sup>), and necrotic (An V<sup>−</sup>/PI<sup>+</sup>) cells. (<i>c</i> and <i>d</i>) Data of patients 2, 18 and 20 are representative of six patients.</p>
                        </div>
                  </figcaption>
               </figure>
            </section>
            </section>
         </section>
      <section class="article-section__content" id="sec1-3">
         
         <h2 class="article-section__title section__title section1" id="sec1-3-title"> Discussion</h2>
         
         <p>The major finding of our study is that GSI I triggers apoptosis of primary CLL cells by inhibiting proteasome activity and enhancing ER stress signaling and amplifies it by blocking Notch activation. This is the first evidence that in CLL, GSI I simultaneously targets three key apoptosis regulators to induce apoptosis, even if the dual activities of GSI I on proteasome and Notch has also been demonstrated in other tumor cells.<span><a href="#bib16" class="bibLink tab-link" id="bib16R" data-tab="pane-pcw-references" aria-label="Reference 16 - Br J Cancer">16</a>-<a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Mol Cancer Res">18</a></span> These findings may have important therapeutic implications for CLL, considering the emerging interest in generating new anticancer multitarget agents, based on the current opinion that anticancer drugs, able to interfere simultaneously with multiple altered pathways, might be more effective than highly selective drugs.<span><a href="#bib4" class="bibLink tab-link" id="bib4R" data-tab="pane-pcw-references" aria-label="Reference 4 - Clin Cancer Res">4</a></span></p>
         
         <p>Our results show that GSI I increases CLL cell apoptosis also in the presence of pro-survival signals triggered by OP9 stromal cells, suggesting the potential to reverse cytoprotection by the microenvironment.</p>
         
         <p>We demonstrate that proteasome inhibition by GSI I occurs concomitant with an increased activation of some ER stress-associated apoptotic pathways and a strong up-regulation of the proapoptotic BH3-only protein Noxa. In CLL cells, GSI I rapidly potentiates a specific ER stress-triggered caspase cascade, initiated by caspase-4 and involving caspase-8 and -3, which is already functional in <i>ex vivo</i> CLL cells and plays an important role in their spontaneous apoptosis.<span><a href="#bib24" class="bibLink tab-link" id="bib24R" data-tab="pane-pcw-references" aria-label="Reference 24 - Blood">24</a></span> GSI I also rapidly increases JNK1/2 phosphorylation and the expression of IRE1α, an ER membrane kinase known to activate the ASK1/JNK pathway of the ER stress response.<span><a href="#bib36" class="bibLink tab-link" id="bib36R" data-tab="pane-pcw-references" aria-label="Reference 36 - Science">36</a></span> The cleavage of the ER stress regulator Bap31 into the pro apoptotic Bap20 fragment is also increased by GSI I, further confirming the involvement of ER stress in GSI I-induced CLL cell apoptosis.</p>
         
         <p>Time-course studies indicate that proteasome inhibition and all ER stress apoptotic events induced by GSI I in CLL cells precede, and some of them contribute to, the activation of the mitochondrial apoptotic pathway, characterized by Bax translocation to mitochondria, release of cytochrome c, Smac/DIABLO and Omi/HtrA2 to the cytosol, and caspase-9 activation. In this context, pharmacologic inhibition studies show that JNK1/2 activation induced by GSI I contributes, at least in part, to the mitochondrial release of cytochrome c and Smac/DIABLO to the cytosol, suggesting its involvement in converging ER stress signals to mitochondria.</p>
         
         <p>Mitochondrial integrity is tightly regulated by a wise balance between proapoptotic and antiapoptotic members of the Bcl-2 family.<span><a href="#bib38" class="bibLink tab-link" id="bib38R" data-tab="pane-pcw-references" aria-label="Reference 38 - Nat Cell Biol">38</a></span> In CLL cells, GSI I increases mitochondrial alterations without down-regulating Bcl-2 expression, and in the presence of a rapid accumulation of the short-lived protein Mcl-1, which can be due either to an inhibited proteasomal degradation<span><a href="#bib42" class="bibLink tab-link" id="bib42R" data-tab="pane-pcw-references" aria-label="Reference 42 - Genes Dev">42</a></span> or an adaptive response to ER stress, as also observed in other tumor cells.<span><a href="#bib43" class="bibLink tab-link" id="bib43R" data-tab="pane-pcw-references" aria-label="Reference 43 - Oncogene">43</a></span> However, the evidence that restraining Mcl-1 accumulation by siRNA increases GSI I-induced CLL cell apoptosis, along with the evidence that GSI I induces mitochondrial perturbations, suggests that Mcl-1 persistence induced by GSI I slows down, but does not impede them. This is probably due to the fact that Mcl-1 could be sequestered by Noxa so allowing Bax and/or Bak to permeabilize mitochondria, as reported elsewhere.<span><a href="#bib44" class="bibLink tab-link" id="bib44R" data-tab="pane-pcw-references" aria-label="Reference 44 - Blood">44</a></span> Consistent with this observation, we show that, in CLL cells, GSI I rapidly induces a strong Noxa protein up-regulation which precedes Bax translocation to mitochondria, thus suggesting that Noxa plays a critical role in GSI I-induced CLL cell apoptosis. We show that Noxa increase depends on new protein synthesis and, especially in the late apoptotic phases, on transcriptional up-regulation. Pharmacologic inhibition studies suggest that a contribution to up-regulating Noxa protein levels is made by the increased JNK1/2 activation induced by GSI I. However, Noxa up-regulation by GSI I may also depend on protein stabilization as a consequence of proteasome inhibition, as occurs in CLL cells treated with the proteasome inhibitors bortezomib and MG132.<span><a href="#bib46" class="bibLink tab-link" id="bib46R" data-tab="pane-pcw-references" aria-label="Reference 46 - Haematologica">46</a></span> Since Noxa is a target of p53<span><a href="#bib47" class="bibLink tab-link" id="bib47R" data-tab="pane-pcw-references" aria-label="Reference 47 - Science">47</a></span> and p53 is regulated by the proteasome,<span><a href="#bib48" class="bibLink tab-link" id="bib48R" data-tab="pane-pcw-references" aria-label="Reference 48 - Cell">48</a></span> the possibility that GSI I increases Noxa mRNA by increasing cellular pools of p53 cannot be excluded.</p>
         
         <p>Another observation of our study is that GSI I inhibits Notch signaling when CLL cell apoptosis has reached the maximum level, whereas in the early apoptotic phases, CLL cells show an accumulation of Notch1 and Notch2 proteins and a stabilization of Hes1 levels. This is probably due to proteasome inhibition because various Notch pathway components have a fast turnover rate and are tightly regulated by the ubiquitin/proteasome system.<span><a href="#bib49" class="bibLink tab-link" id="bib49R" data-tab="pane-pcw-references" aria-label="Reference 49 - Mol Cell Biol">49</a></span> The evidence that GSI I inhibits Notch signaling in the late apoptotic phases suggests that Notch inhibition is not crucial in initiating CLL cell apoptosis and therefore, that the key events induced by GSI I to trigger CLL cell apoptosis are the proteasome inhibition and the increase in ER stress. Notch inhibition by GSI I contributes to amplify CLL cell apoptosis because Notch signaling has a pro-survival role in these cells, as demonstrated by the evidence that silencing either Notch1 or Notch2 accelerates spontaneous CLL cell apoptosis.</p>
         
         <p>The extent to which the inhibition of Notch and proteasome by GSI I contributes to apoptosis has also been investigated in other malignancies. In breast cancer cell lines<span><a href="#bib17" class="bibLink tab-link" id="bib17R" data-tab="pane-pcw-references" aria-label="Reference 17 - Breast Cancer Res">17</a></span> and in glioblastoma tumor cells,<span><a href="#bib18" class="bibLink tab-link" id="bib18R" data-tab="pane-pcw-references" aria-label="Reference 18 - Mol Cancer Res">18</a></span> the main target of GSI I is the proteasome. In precursor-B ALL cells, GSI I induces apoptosis by inhibiting Notch signaling and through Notch-independent mechanisms including, besides proteasome inhibition, the increase of reactive oxygen species production and the disruption of the AKT pro-survival pathway.<span><a href="#bib19" class="bibLink tab-link" id="bib19R" data-tab="pane-pcw-references" aria-label="Reference 19 - Leukemia">19</a></span> The ability of GSI I to target Notch, AKT and other pro-survival pathways, has also been shown in cutaneous T-cell lymphoma.<span><a href="#bib50" class="bibLink tab-link" id="bib50R" data-tab="pane-pcw-references" aria-label="Reference 50 - Blood">50</a></span> All these findings have led to an in-depth understanding of the mechanisms of action of GSI I in tumor cells which is essential to define the potential clinical use of GSI I.</p>
         
         <p>In this study, we provide the molecular basis of GSI I-induced apoptosis of CLL cells and support the notion that simultaneously targeting proteasome, ER and Notch can be exploited as a novel therapeutic approach for CLL.</p>
         </section>
      <div class="article-section__content">
         
         <h2 class="article-section__title section__title section1" id="sec1-ack-1-title"> Acknowledgements</h2>
         
         <p>This work was supported by a grant from Progetti di Ricerca di Interesse Nazionale-PRIN (2008, prot. 2008YSSL7B_003; to P.M.), by the Fondazione Cassa di Risparmio di Perugia, Italy (2009, code 2009.020.0086; to E.R.), and by the Associazione Italiana per la Ricerca sul Cancro (to I.S.).</p>
         
         <ol></ol>
      </div>
      <section class="article-section article-section__supporting" data-suppl="/doi/suppl/10.1002/ijc.27863?onlyLog=true">
         <div class="accordion article-accordion">
            <h2><a class="accordion__control" role="button" aria-controls="d14195270e315" aria-expanded="false">
                  <div tabindex="0" class="section__title" id="support-information-section"><span>Supporting Information</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></a></h2>
            <div class="accordion__content" role="region" aria-labelledby="support-information-section" style="display: none;" id="d14195270e315" aria-hidden="false">
               <div class="support-info__table-wrapper article-table-content-wrapper">
                  <p>
Additional Supporting Information may be found in the online version of this article.





</p>
                  
                  
                  
                  
                  
                  
                  <table class="support-info__table table article-section__table">
                     <thead>
                        <th id="article-filename" scope="col">Filename</th>
                        <th id="article-description" scope="col">Description</th>
                     </thead>
                     <tbody>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27863&amp;file=IJC_27863_sm_SuppFig1.tif">IJC_27863_sm_SuppFig1.tif</a>279 KB</td>
                           <td headers="article-description">Supporting Information Figure 1. GSI I increases CLL cell apoptosis in a dose-dependent manner. Freshly isolated CLL cells (n = 22) were exposed for 24 hr to the indicated GSI I concentrations or 0.01% DMSO. Cell viability and apoptosis were evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining, and results are presented as the percentage of viable (An V-/PI-), early apoptotic (An V+/PI-), late apoptotic (An V+/PI+), and necrotic (An V-/PI+) cells. (a) Results are the mean ± SD of 22 patients. **p &lt; 0.01 (An V-/PI- cells at each dose of GSI I versus An V-/PI- cells in DMSO) according to Student's t test. (b) Results shown for patient 2 are representative of 22 patients.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27863&amp;file=IJC_27863_sm_SuppFig2.tif">IJC_27863_sm_SuppFig2.tif</a>288.6 KB</td>
                           <td headers="article-description">Supporting Information Figure 2. GSI I increases CLL cell apoptosis by potentiating an ER stress-specific caspase cascade initiated by caspase-4. (a) Effect of pharmacologic caspase inhibition on viability of CLL cells treated with GSI I. Freshly isolated CLL cells (n = 6) were pretreated for 2 hr with 50 ?M of the caspase-4 inhibitor z-LEVD-fmk, 50 ?M of the pan-caspase inhibitor z-VAD-fmk or 0.005% DMSO as control, exposed for 12 hr to 2.5 ?M GSI I, and then analyzed for Annexin V/PI (An V/PI) staining. Results are presented as the percentage of viable (An V-/PI-) cells and are the mean ± SD of 6 patients. **p &lt; 0.01 (cells treated with each caspase inhibitor and GSI I versus cells treated with GSI I) according to Student's t test. (b) Effect of pharmacologic caspase-4 inhibition on caspase-8 and -3 processing induced by GSI I. Western blot analysis was performed in 20 ?g whole-cell lysates extracted from CLL cells treated with the caspase-4 inhibitor and GSI I as in panel a, and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody (n = 6). Vertical lines inserted in the blots indicate a repositioned gel lane. Results shown for patient 2 are representative of 6 patients.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27863&amp;file=IJC_27863_sm_SuppFig3.tif">IJC_27863_sm_SuppFig3.tif</a>348.1 KB</td>
                           <td headers="article-description">Supporting Information Figure 3. Notch2 down-regulation by siRNA increases CLL cell apoptosis. Freshly isolated CLL cells (n = 6) were transfected with 0.5 ?M of control nontargeting (siCtrl) or Notch2 siRNA as described in “siRNA nucleofection” and then cultured for 72 hr in supernatants harvested from 48-hr cultures of OP9 cell line. (a) Western blot analysis of Notch2 was performed in 20 ?g whole-cell lysates, and protein loading was assessed by reprobing the blots with an anti-GAPDH antibody. (b) Apoptosis was evaluated by flow cytometric analysis of Annexin V/PI (An V/PI) staining. Results are presented as the percentage of viable (An V-/PI-), early apoptotic (An V+/PI-), late apoptotic (An V+/PI+), and necrotic (An V-/PI+) cells. (a and b) Data of patients 2, 18 and 20 are representative of 6 patients.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27863&amp;file=IJC_27863_sm_SuppTab1.doc">IJC_27863_sm_SuppTab1.doc</a>55 KB</td>
                           <td headers="article-description">Supporting Information Table 1.</td>
                        </tr>
                        <tr id="">
                           <td headers="article-filename"><a href="/action/downloadSupplement?doi=10.1002%2Fijc.27863&amp;file=IJC_27863_sm_SuppTab2.doc">IJC_27863_sm_SuppTab2.doc</a>42 KB</td>
                           <td headers="article-description">Supporting Information Table 2.</td>
                        </tr>
                     </tbody>
                  </table>
                  <p class="disclaimer_text">Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.</p>
               </div>
            </div>
         </div>
      </section>
      <section class="article-section article-section__references" id="references-section">
         <div class="accordion article-accordion">
            <h2>
               <div tabindex="0" role="button" class="accordion__control" aria-expanded="false" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&ajax=true&doi=10.1002%2Fijc.27863&pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215&accordionHeadingWrapper=h2&onlyLog=true"><span class="section__title" id="references-section-1">References</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div>
            </h2>
            <div class="accordion__content" style="display: none;" role="region" aria-labelledby="references-section-1">
               <ul class="rlist separator">
                  
                  
                  <li data-bib-id="bib1"><span class="bullet">1</span>
                     <span class="author">Chiorazzi N</span>,
<span class="author">Rai KR</span>,
<span class="author">Ferrarini M</span>.
<span class="articleTitle">Chronic lymphocytic leukemia</span>.
<i>N Engl J Med</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">352</span>:
 <span class="pageFirst">804</span>– <span class="pageLast">15</span>.
                     <div class="extra-links" id="e_1_2_6_2_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1056%2FNEJMra041720" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFCiu74%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=15728813" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000227147500010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=804-15&journal=N+Engl+J+Med&author=N+Chiorazzi&author=KR+Rai&author=M+Ferrarini&title=Chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib2"><span class="bullet">2</span>
                     <span class="author">Lin TS</span>.
<span class="articleTitle">New agents in chronic lymphocytic leukemia</span>.
<i>Curr Hematol Malig Rep</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">5</span>:
 <span class="pageFirst">29</span>– <span class="pageLast">34</span>.
                     <div class="extra-links" id="e_1_2_6_3_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1007%2Fs11899-009-0039-9" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=15458576" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=29-34&journal=Curr+Hematol+Malig+Rep&author=TS+Lin&title=New+agents+in+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib3"><span class="bullet">3</span>
                     <span class="author">Zenz T</span>,
<span class="author">Mertens D</span>,
<span class="author">Küppers R</span>, et al.
<span class="articleTitle">From pathogenesis to treatment of chronic lymphocytic leukaemia</span>.
<i>Nat Rev Cancer</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">10</span>:
 <span class="pageFirst">37</span>– <span class="pageLast">50</span>.
                     <div class="extra-links" id="e_1_2_6_4_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fnrc2764" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSgt7jN" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19956173" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000273809000012" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=37-50&journal=Nat+Rev+Cancer&author=T+Zenz&author=D+Mertens&author=R+K%C3%BCppers&title=From+pathogenesis+to+treatment+of+chronic+lymphocytic+leukaemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib4"><span class="bullet">4</span>
                     <span class="author">Gossage L</span>,
<span class="author">Eisen T</span>.
<span class="articleTitle">Targeting multiple kinase pathways: a change in paradigm</span>.
<i>Clin Cancer Res</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">16</span>:
 <span class="pageFirst">1973</span>– <span class="pageLast">78</span>.
                     <div class="extra-links" id="e_1_2_6_5_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1158%2F1078-0432.CCR-09-3182" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFygu7w%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=20215532" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000278595800001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1973-78&journal=Clin+Cancer+Res&author=L+Gossage&author=T+Eisen&title=Targeting+multiple+kinase+pathways%3A+a+change+in+paradigm"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib5"><span class="bullet">5</span>
                     <span class="author">Petrelli A</span>,
<span class="author">Giordano S</span>.
<span class="articleTitle">From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage</span>.
<i>Curr Med Chem</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">15</span>:
 <span class="pageFirst">422</span>– <span class="pageLast">32</span>.
                     <div class="extra-links" id="e_1_2_6_6_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.2174%2F092986708783503212" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyisL0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18288997" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000253990400001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=422-32&journal=Curr+Med+Chem&author=A+Petrelli&author=S+Giordano&title=From+single%E2%80%90+to+multi%E2%80%90target+drugs+in+cancer+therapy%3A+when+aspecificity+becomes+an+advantage"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib6"><span class="bullet">6</span>
                     <span class="author">Rizzo P</span>,
<span class="author">Osipo C</span>,
<span class="author">Foreman K</span>, et al.
<span class="articleTitle">Rational targeting of Notch signaling in cancer</span>.
<i>Oncogene</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">27</span>:
 <span class="pageFirst">5124</span>– <span class="pageLast">31</span>.
                     <div class="extra-links" id="e_1_2_6_7_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fonc.2008.226" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGgtLfM" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18758481" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000258914900006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5124-31&journal=Oncogene&author=P+Rizzo&author=C+Osipo&author=K+Foreman&title=Rational+targeting+of+Notch+signaling+in+cancer"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib7"><span class="bullet">7</span>
                     <span class="author">Leong KG</span>,
<span class="author">Karsan A</span>.
<span class="articleTitle">Recent insights into the role of Notch signaling in tumorigenesis</span>.
<i>Blood</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">107</span>:
 <span class="pageFirst">2223</span>– <span class="pageLast">33</span>.
                     <div class="extra-links" id="e_1_2_6_8_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2005-08-3329" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFOjt7s%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16291593" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000236014200011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=2223-33&journal=Blood&author=KG+Leong&author=A+Karsan&title=Recent+insights+into+the+role+of+Notch+signaling+in+tumorigenesis"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib8"><span class="bullet">8</span>
                     <span class="author">Nefedova Y</span>,
<span class="author">Gabrilovich D</span>.
<span class="articleTitle">Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies</span>.
<i>Drug Resist Updat</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">11</span>:
 <span class="pageFirst">210</span>– <span class="pageLast">18</span>.
                     <div class="extra-links" id="e_1_2_6_9_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1016%2Fj.drup.2008.09.002" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWhs7fJ" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18951834" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000261503700002" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=210-18&journal=Drug+Resist+Updat&author=Y+Nefedova&author=D+Gabrilovich&title=Mechanisms+and+clinical+prospects+of+Notch+inhibitors+in+the+therapy+of+hematological+malignancies"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib9"><span class="bullet">9</span>
                     <span class="author">Rosati E</span>,
<span class="author">Sabatini R</span>,
<span class="author">Rampino G</span>, et al.
<span class="articleTitle">Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells</span>.
<i>Blood</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">113</span>:
 <span class="pageFirst">856</span>– <span class="pageLast">65</span>.
                     <div class="extra-links" id="e_1_2_6_10_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2008-02-139725" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGhtLs%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18796623" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000262646200014" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=856-65&journal=Blood&author=E+Rosati&author=R+Sabatini&author=G+Rampino&title=Constitutively+activated+Notch+signaling+is+involved+in+survival+and+apoptosis+resistance+of+B%E2%80%90CLL+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib10"><span class="bullet">10</span>
                     <span class="author">Krop IE</span>,
<span class="author">Kosh M</span>,
<span class="author">Fearen I</span>, et al.
<span class="articleTitle">Phase I pharmacokinetic (PK), and pharmacodynamic (PD) trial of the novel oral Notch inhibitor MK-0752 in patients (pts) with advanced breast cancer (BC) and other solid tumors (Meeting Abstract)</span>.
<i>J Clin Oncol</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">24</span>:
 <span class="pageFirst">10574</span>.
                     <div class="extra-links" id="e_1_2_6_11_2"><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=10574&journal=J+Clin+Oncol&author=IE+Krop&author=M+Kosh&author=I+Fearen&title=Phase+I+pharmacokinetic+%28PK%29%2C+and+pharmacodynamic+%28PD%29+trial+of+the+novel+oral+Notch+inhibitor+MK%E2%80%900752+in+patients+%28pts%29+with+advanced+breast+cancer+%28BC%29+and+other+solid+tumors+%28Meeting+Abstract%29"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib11"><span class="bullet">11</span>
                     <span class="author">Deangelo DJ</span>,
<span class="author">Stone RM</span>,
<span class="author">Silverman LB</span>, et al.
<span class="articleTitle">A phase I clinical trial of the Notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias (Meeting Abstract)</span>.
<i>J Clin Oncol</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">24</span>:
 <span class="pageFirst">6585</span>.
                     <div class="extra-links" id="e_1_2_6_12_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000239009402298" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=6585&journal=J+Clin+Oncol&author=DJ+Deangelo&author=RM+Stone&author=LB+Silverman&title=A+phase+I+clinical+trial+of+the+Notch+inhibitor+MK%E2%80%900752+in+patients+with+T%E2%80%90cell+acute+lymphoblastic+leukemia%2Flymphoma+%28T%E2%80%90ALL%29+and+other+leukemias+%28Meeting+Abstract%29"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib12"><span class="bullet">12</span>
                     <span class="author">Vilimas T</span>,
<span class="author">Mascarenhas J</span>,
<span class="author">Palomero T</span>, et al.
<span class="articleTitle">Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia</span>.
<i>Nat Med</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">13</span>:
 <span class="pageFirst">70</span>– <span class="pageLast">7</span>.
                     <div class="extra-links" id="e_1_2_6_13_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fnm1524" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFWisA%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=17173050" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000243301800038" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=70-7&journal=Nat+Med&author=T+Vilimas&author=J+Mascarenhas&author=T+Palomero&title=Targeting+the+NF%E2%80%90kappaB+signaling+pathway+in+Notch1%E2%80%90induced+T%E2%80%90cell+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib13"><span class="bullet">13</span>
                     <span class="author">De Keersmaecker K</span>,
<span class="author">Lahortiga I</span>,
<span class="author">Mentens N</span>, et al.
<span class="articleTitle">In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia</span>.
<i>Haematologica</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">93</span>:
 <span class="pageFirst">533</span>– <span class="pageLast">42</span>.
                     <div class="extra-links" id="e_1_2_6_14_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.3324%2Fhaematol.11894" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSiu73E" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18322257" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000254705200010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2008&pages=533-42&journal=Haematologica&author=K+De+Keersmaecker&author=I+Lahortiga&author=N+Mentens&title=In+vitro+validation+of+gamma%E2%80%90secretase+inhibitors+alone+or+in+combination+with+other+anti%E2%80%90cancer+drugs+for+the+treatment+of+T%E2%80%90cell+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib14"><span class="bullet">14</span>
                     <span class="author">Pandya K</span>,
<span class="author">Meeke K</span>,
<span class="author">Clementz AG</span>, et al.
<span class="articleTitle">Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence</span>.
<i>Br J Cancer</i>
                     <span class="pubYear">2011</span>;
 <span class="vol">105</span>:
 <span class="pageFirst">796</span>– <span class="pageLast">806</span>.
                     <div class="extra-links" id="e_1_2_6_15_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fbjc.2011.321" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCqt7bF" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=21847123" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000294611800009" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=796-806&journal=Br+J+Cancer&author=K+Pandya&author=K+Meeke&author=AG+Clementz&title=Targeting+both+Notch+and+ErbB%E2%80%902+signalling+pathways+is+required+for+prevention+of+ErbB%E2%80%902%E2%80%90positive+breast+tumour+recurrence"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib15"><span class="bullet">15</span>
                     <span class="author">Weinmaster G</span>,
<span class="author">Kopan R</span>.
<span class="articleTitle">A garden of Notch-ly delights</span>.
<i>Development</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">133</span>:
 <span class="pageFirst">3277</span>– <span class="pageLast">82</span>.
                     <div class="extra-links" id="e_1_2_6_16_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1242%2Fdev.02515" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hsLjJ" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16908627" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000239758700001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2006&pages=3277-82&journal=Development&author=G+Weinmaster&author=R+Kopan&title=A+garden+of+Notch%E2%80%90ly+delights"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib16"><span class="bullet">16</span>
                     <span class="author">Rasul S</span>,
<span class="author">Balasubramanian R</span>,
<span class="author">Filipović A</span>, et al.
<span class="articleTitle">Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells</span>.
<i>Br J Cancer</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">100</span>:
 <span class="pageFirst">1879</span>– <span class="pageLast">88</span>.
                     <div class="extra-links" id="e_1_2_6_17_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fsj.bjc.6605034" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFyguro%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19513078" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000267817700008" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=1879-88&journal=Br+J+Cancer&author=S+Rasul&author=R+Balasubramanian&author=A+Filipovi%C4%87&title=Inhibition+of+%CE%B3%E2%80%90secretase+induces+G2%2FM+arrest+and+triggers+apoptosis+in+breast+cancer+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib17"><span class="bullet">17</span>
                     <span class="author">Han J</span>,
<span class="author">Ma I</span>,
<span class="author">Hendzel MJ</span>, et al.
<span class="articleTitle">The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition</span>.
<i>Breast Cancer Res</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">11</span>:
 <span class="pageFirst">R57</span>.
                     <div class="extra-links" id="e_1_2_6_18_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1186%2Fbcr2347" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVemtrjI" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19660128" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000271414000020" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=R57&journal=Breast+Cancer+Res&author=J+Han&author=I+Ma&author=MJ+Hendzel&title=The+cytotoxicity+of+%CE%B3%E2%80%90secretase+inhibitor+I+to+breast+cancer+cells+is+mediated+by+proteasome+inhibition%2C+not+by+%CE%B3%E2%80%90secretase+inhibition"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib18"><span class="bullet">18</span>
                     <span class="author">Monticone M</span>,
<span class="author">Biollo E</span>,
<span class="author">Fabiano A</span>, et al.
<span class="articleTitle">z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response</span>.
<i>Mol Cancer Res</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">7</span>:
 <span class="pageFirst">1822</span>– <span class="pageLast">34</span>.
                     <div class="extra-links" id="e_1_2_6_19_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1158%2F1541-7786.MCR-09-0225" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVamsrzJ" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19861404" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000272006300008" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1822-34&journal=Mol+Cancer+Res&author=M+Monticone&author=E+Biollo&author=A+Fabiano&title=z%E2%80%90Leucinyl%E2%80%90leucinyl%E2%80%90norleucinal+induces+apoptosis+of+human+glioblastoma+tumor%E2%80%90initiating+cells+by+proteasome+inhibition+and+mitotic+arrest+response"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib19"><span class="bullet">19</span>
                     <span class="author">Meng X</span>,
<span class="author">Matlawska-Wasowska K</span>,
<span class="author">Girodon F</span>, et al.
<span class="articleTitle">GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia</span>.
<i>Leukemia</i>
                     <span class="pubYear">2011</span>;
 <span class="vol">25</span>:
 <span class="pageFirst">1135</span>– <span class="pageLast">46</span>.
                     <div class="extra-links" id="e_1_2_6_20_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fleu.2011.50" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOiu7s%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=21494254" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000292682600009" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1135-46&journal=Leukemia&author=X+Meng&author=K+Matlawska%E2%80%90Wasowska&author=F+Girodon&title=GSI%E2%80%90I+%28Z%E2%80%90LLNle%E2%80%90CHO%29+inhibits+%CE%B3%E2%80%90secretase+and+the+proteosome+to+trigger+cell+death+in+precursor%E2%80%90B+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib20"><span class="bullet">20</span>
                     <span class="author">Masdehors P</span>,
<span class="author">Merle-Béral H</span>,
<span class="author">Maloum K</span>, et al.
<span class="articleTitle">Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes</span>.
<i>Blood</i>
                     <span class="pubYear">2000</span>;
 <span class="vol">96</span>:
 <span class="pageFirst">269</span>– <span class="pageLast">74</span>.
                     <div class="extra-links" id="e_1_2_6_21_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVKjt7w%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=10891461" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000087813200040" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=269-74&journal=Blood&author=P+Masdehors&author=H+Merle%E2%80%90B%C3%A9ral&author=K+Maloum&title=Deregulation+of+the+ubiquitin+system+and+p53+proteolysis+modify+the+apoptotic+response+in+B%E2%80%90CLL+lymphocytes"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib21"><span class="bullet">21</span>
                     <span class="author">Faderl S</span>,
<span class="author">Rai K</span>,
<span class="author">Gribben J</span>, et al.
<span class="articleTitle">Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia</span>.
<i>Cancer</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">107</span>:
 <span class="pageFirst">916</span>– <span class="pageLast">24</span>.
                     <div class="extra-links" id="e_1_2_6_22_2"><span><a href="/doi/10.1002/cncr.22097" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCrtL0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16832816" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000240054200004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=916-24&journal=Cancer&author=S+Faderl&author=K+Rai&author=J+Gribben&title=Phase+II+study+of+single%E2%80%90agent+bortezomib+for+the+treatment+of+patients+with+fludarabine%E2%80%90refractory+B%E2%80%90cell+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib22"><span class="bullet">22</span>
                     <span class="author">Werner ED</span>,
<span class="author">Brodsky JL</span>,
<span class="author">McCracken AA</span>.
<span class="articleTitle">Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate</span>.
<i>Proc Natl Acad Sci USA</i>
                     <span class="pubYear">1996</span>;
 <span class="vol">93</span>:
 <span class="pageFirst">13797</span>– <span class="pageLast">801</span>.
                     <div class="extra-links" id="e_1_2_6_23_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1073%2Fpnas.93.24.13797" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1GmsLY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=8943015" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=A1996VV46700063" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=13797-801&journal=Proc+Natl+Acad+Sci+USA&author=ED+Werner&author=JL+Brodsky&author=AA+McCracken&title=Proteasome%E2%80%90dependent+endoplasmic+reticulum%E2%80%90associated+protein+degradation%3A+an+unconventional+route+to+a+familiar+fate"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib23"><span class="bullet">23</span>
                     <span class="author">Fribley A</span>,
<span class="author">Wang CY</span>.
<span class="articleTitle">Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress</span>.
<i>Cancer Biol Ther</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">5</span>:
 <span class="pageFirst">745</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_6_24_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.4161%2Fcbt.5.7.2971" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOju77J" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16861900" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000240705300015" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=745-8&journal=Cancer+Biol+Ther&author=A+Fribley&author=CY+Wang&title=Proteasome+inhibitor+induces+apoptosis+through+induction+of+endoplasmic+reticulum+stress"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib24"><span class="bullet">24</span>
                     <span class="author">Rosati E</span>,
<span class="author">Sabatini R</span>,
<span class="author">Rampino G</span>, et al.
<span class="articleTitle">Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL</span>.
<i>Blood</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">116</span>:
 <span class="pageFirst">2713</span>– <span class="pageLast">23</span>.
                     <div class="extra-links" id="e_1_2_6_25_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2010-03-275628" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSktbzF" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=20628148" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000282956700018" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=2713-23&journal=Blood&author=E+Rosati&author=R+Sabatini&author=G+Rampino&title=Novel+targets+for+endoplasmic+reticulum+stress%E2%80%90induced+apoptosis+in+B%E2%80%90CLL"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib25"><span class="bullet">25</span>
                     <span class="author">Carew JS</span>,
<span class="author">Nawrocki ST</span>,
<span class="author">Krupnik YV</span>, et al.
<span class="articleTitle">Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL</span>.
<i>Blood</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">107</span>:
 <span class="pageFirst">222</span>– <span class="pageLast">31</span>.
                     <div class="extra-links" id="e_1_2_6_26_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2005-05-1923" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGmtw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16144803" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000234235200041" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=222-31&journal=Blood&author=JS+Carew&author=ST+Nawrocki&author=YV+Krupnik&title=Targeting+endoplasmic+reticulum+protein+transport%3A+a+novel+strategy+to+kill+malignant+B+cells+and+overcome+fludarabine+resistance+in+CLL"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib26"><span class="bullet">26</span>
                     <span class="author">Hallek M</span>,
<span class="author">Cheson BD</span>,
<span class="author">Catovsky D</span>, et al.
<span class="articleTitle">Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines</span>.
<i>Blood</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">111</span>:
 <span class="pageFirst">5446</span>– <span class="pageLast">56</span>.
                     <div class="extra-links" id="e_1_2_6_27_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2007-06-093906" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOktrk%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18216293" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000256786500014" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5446-56&journal=Blood&author=M+Hallek&author=BD+Cheson&author=D+Catovsky&title=Guidelines+for+the+diagnosis+and+treatment+of+chronic+lymphocytic+leukemia%3A+a+report+from+the+International+Workshop+on+Chronic+Lymphocytic+Leukemia+%28IWCLL%29+updating+the+National+Cancer+Institute%E2%80%90Working+Group+%28NCI%E2%80%90WG%29+1996+guidelines"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib27"><span class="bullet">27</span>
                     <span class="author">Binet JL</span>,
<span class="author">Lepoprier M</span>,
<span class="author">Dighiero G</span>, et al.
<span class="articleTitle">A clinical staging system for chronic lymphocytic leukemia: prognostic significance</span>.
<i>Cancer</i>
                     <span class="pubYear">1977</span>;
 <span class="vol">40</span>:
 <span class="pageFirst">855</span>– <span class="pageLast">64</span>.
                     <div class="extra-links" id="e_1_2_6_28_2"><span><a href="/doi/10.1002/1097-0142%28197708%2940%3A2%3C855%3A%3AAID-CNCR2820400239%3E3.0.CO%3B2-1" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ASTN%3A280%3ADyaE2s3ktlyltA%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=890666" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=A1977DU12000038" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1977&pages=855-64&journal=Cancer&author=JL+Binet&author=M+Lepoprier&author=G+Dighiero&title=A+clinical+staging+system+for+chronic+lymphocytic+leukemia%3A+prognostic+significance"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib28"><span class="bullet">28</span>
                     <span class="author">van Dongen JJ</span>,
<span class="author">Langerak AW</span>,
<span class="author">Brüggemann M</span>, et al.
<span class="articleTitle">Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936</span>.
<i>Leukemia</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">17</span>:
 <span class="pageFirst">2257</span>– <span class="pageLast">317</span>.
                     <div class="extra-links" id="e_1_2_6_29_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fsj.leu.2403202" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ASTN%3A280%3ADC%252BD3srovFOhtA%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=14671650" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000187183200001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2257-317&journal=Leukemia&author=JJ+van+Dongen&author=AW+Langerak&author=M+Br%C3%BCggemann&title=Design+and+standardization+of+PCR+primers+and+protocols+for+detection+of+clonal+immunoglobulin+and+T%E2%80%90cell+receptor+gene+recombinations+in+suspect+lymphoproliferations%3A+report+of+the+BIOMED%E2%80%902+concerted+action+BMH4%E2%80%90CT98%E2%80%903936"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib29"><span class="bullet">29</span>
                     <span class="author">Crespo M</span>,
<span class="author">Bosch F</span>,
<span class="author">Villamor N</span>, et al.
<span class="articleTitle">ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia</span>.
<i>N Engl J Med</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">348</span>:
 <span class="pageFirst">1764</span>– <span class="pageLast">75</span>.
                     <div class="extra-links" id="e_1_2_6_30_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1056%2FNEJMoa023143" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlWqsro%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=12724482" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000182543500005" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1764-75&journal=N+Engl+J+Med&author=M+Crespo&author=F+Bosch&author=N+Villamor&title=ZAP%E2%80%9070+expression+as+a+surrogate+for+immunoglobulin%E2%80%90variable%E2%80%90region+mutations+in+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib30"><span class="bullet">30</span>
                     <span class="author">Di Ianni M</span>,
<span class="author">Baldoni S</span>,
<span class="author">Rosati E</span>, et al.
<span class="articleTitle">A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation</span>.
<i>Br J Haematol</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">146</span>:
 <span class="pageFirst">689</span>– <span class="pageLast">91</span>.
                     <div class="extra-links" id="e_1_2_6_31_2"><span><a href="/doi/10.1111/j.1365-2141.2009.07816.x" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Srt7vM" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19604236" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000269538200016" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2009&pages=689-91&journal=Br+J+Haematol&author=M+Di+Ianni&author=S+Baldoni&author=E+Rosati&title=A+new+genetic+lesion+in+B%E2%80%90CLL%3A+a+NOTCH1+PEST+domain+mutation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib31"><span class="bullet">31</span>
                     <span class="author">Weng AP</span>,
<span class="author">Ferrando AA</span>,
<span class="author">Lee W</span>, et al.
<span class="articleTitle">Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia</span>.
<i>Science</i>
                     <span class="pubYear">2004</span>;
 <span class="vol">306</span>:
 <span class="pageFirst">269</span>– <span class="pageLast">71</span>.
                     <div class="extra-links" id="e_1_2_6_32_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1126%2Fscience.1102160" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFWnsbo%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=15472075" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000224419700038" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2004&pages=269-71&journal=Science&author=AP+Weng&author=AA+Ferrando&author=W+Lee&title=Activating+mutations+of+NOTCH1+in+human+T+cell+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib32"><span class="bullet">32</span>
                     <span class="author">Kurtova AV</span>,
<span class="author">Balakrishnan K</span>,
<span class="author">Chen R</span>, et al.
<span class="articleTitle">Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance</span>.
<i>Blood</i>
                     <span class="pubYear">2009</span>;
 <span class="vol">114</span>:
 <span class="pageFirst">4441</span>– <span class="pageLast">50</span>.
                     <div class="extra-links" id="e_1_2_6_33_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2009-07-233718" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsLvF" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=19762485" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000271727500016" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=4441-50&journal=Blood&author=AV+Kurtova&author=K+Balakrishnan&author=R+Chen&title=Diverse+marrow+stromal+cells+protect+CLL+cells+from+spontaneous+and+drug%E2%80%90induced+apoptosis%3A+development+of+a+reliable+and+reproducible+system+to+assess+stromal+cell+adhesion%E2%80%90mediated+drug+resistance"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib33"><span class="bullet">33</span>
                     <span class="author">McConkey DJ</span>,
<span class="author">Zhu K</span>.
<span class="articleTitle">Mechanisms of proteasome inhibitor action and resistance in cancer</span>.
<i>Drug Resist Updat</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">11</span>:
 <span class="pageFirst">164</span>– <span class="pageLast">79</span>.
                     <div class="extra-links" id="e_1_2_6_34_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1016%2Fj.drup.2008.08.002" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2ku7fJ" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18818117" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000260763200003" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=164-79&journal=Drug+Resist+Updat&author=DJ+McConkey&author=K+Zhu&title=Mechanisms+of+proteasome+inhibitor+action+and+resistance+in+cancer"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib34"><span class="bullet">34</span>
                     <span class="author">Oyadomari, S</span>,
<span class="author">Mori M</span>.
<span class="articleTitle">Roles of CHOP/GADD153 in endoplasmic reticulum stress</span>.
<i>Cell Death Differ</i>
                     <span class="pubYear">2004</span>;
 <span class="vol">11</span>:
 <span class="pageFirst">381</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_6_35_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fsj.cdd.4401373" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXit12ntbc%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=14685163" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000220693100004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=381-9&journal=Cell+Death+Differ&author=S+Oyadomari&author=M+Mori&title=Roles+of+CHOP%2FGADD153+in+endoplasmic+reticulum+stress"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib35"><span class="bullet">35</span>
                     <span class="author">Breckenridge DG</span>,
<span class="author">Stojanovic M</span>,
<span class="author">Marcellus RC</span>, et al.
<span class="articleTitle">Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol</span>.
<i>J Cell Biol</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">160</span>:
 <span class="pageFirst">1115</span>– <span class="pageLast">27</span>.
                     <div class="extra-links" id="e_1_2_6_36_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1083%2Fjcb.200212059" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOmsrw%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=12668660" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000182008300015" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2003&pages=1115-27&journal=J+Cell+Biol&author=DG+Breckenridge&author=M+Stojanovic&author=RC+Marcellus&title=Caspase+cleavage+product+of+BAP31+induces+mitochondrial+fission+through+endoplasmic+reticulum+calcium+signals%2C+enhancing+cytochrome+c+release+to+the+cytosol"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib36"><span class="bullet">36</span>
                     <span class="author">Urano F</span>,
<span class="author">Wang X</span>,
<span class="author">Bertolotti A</span>, et al.
<span class="articleTitle">Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1</span>.
<i>Science</i>
                     <span class="pubYear">2000</span>;
 <span class="vol">287</span>:
 <span class="pageFirst">664</span>– <span class="pageLast">6</span>.
                     <div class="extra-links" id="e_1_2_6_37_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1126%2Fscience.287.5453.664" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVyhuw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=10650002" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000084989400051" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=664-6&journal=Science&author=F+Urano&author=X+Wang&author=A+Bertolotti&title=Coupling+of+stress+in+the+ER+to+activation+of+JNK+protein+kinases+by+transmembrane+protein+kinase+IRE1"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib37"><span class="bullet">37</span>
                     <span class="author">Walter L</span>,
<span class="author">Hajnóczky G</span>.
<span class="articleTitle">Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk</span>.
<i>J Bioenerg Biomembr</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">37</span>:
 <span class="pageFirst">191</span>– <span class="pageLast">206</span>.
                     <div class="extra-links" id="e_1_2_6_38_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1007%2Fs10863-005-6600-x" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWiu7%252FN" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=16167176" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000231940100011" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=191-206&journal=J+Bioenerg+Biomembr&author=L+Walter&author=G+Hajn%C3%B3czky&title=Mitochondria+and+endoplasmic+reticulum%3A+the+lethal+interorganelle+cross%E2%80%90talk"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib38"><span class="bullet">38</span>
                     <span class="author">Kim H</span>,
<span class="author">Rafiuddin-Shah M</span>,
<span class="author">Tu HC</span>, et al.
<span class="articleTitle">Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies</span>.
<i>Nat Cell Biol</i>
                     <span class="pubYear">2006</span>;
 <span class="vol">8</span>:
 <span class="pageFirst">1348</span>– <span class="pageLast">58</span>.
                     <div class="extra-links" id="e_1_2_6_39_2"><span><a href="/doi/10.1046/j.1471-4159.2003.02299.x" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kju73F" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=17115033" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000242419800010" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1348-58&journal=Nat+Cell+Biol&author=H+Kim&author=M+Rafiuddin%E2%80%90Shah&author=HC+Tu&title=Hierarchical+regulation+of+mitochondrion%E2%80%90dependent+apoptosis+by+BCL%E2%80%902+subfamilies"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib39"><span class="bullet">39</span>
                     <span class="author">Packham G</span>,
<span class="author">Stevenson FK</span>.
<span class="articleTitle">Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia</span>.
<i>Immunology</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">114</span>:
 <span class="pageFirst">441</span>– <span class="pageLast">9</span>.
                     <div class="extra-links" id="e_1_2_6_40_2"><span><a href="/doi/10.1111/j.1365-2567.2005.02117.x" onclick="newWindow(this.href);return false" class="visitable">Wiley Online Library</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFeqtL0%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=15804279" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000227836600001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2005&pages=441-9&journal=Immunology&author=G+Packham&author=FK+Stevenson&title=Bodyguards+and+assassins%3A+Bcl%E2%80%902+family+proteins+and+apoptosis+control+in+chronic+lymphocytic+leukaemia"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib40"><span class="bullet">40</span>
                     <span class="author">Pepper C</span>,
<span class="author">Lin TT</span>,
<span class="author">Pratt G</span>, et al.
<span class="articleTitle">Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers</span>.
<i>Blood</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">112</span>:
 <span class="pageFirst">3807</span>– <span class="pageLast">17</span>.
                     <div class="extra-links" id="e_1_2_6_41_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2008-05-157131" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCntrjF" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=18599795" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000260301800041" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=3807-17&journal=Blood&author=C+Pepper&author=TT+Lin&author=G+Pratt&title=Mcl%E2%80%901+expression+has+in+vitro+and+in+vivo+significance+in+chronic+lymphocytic+leukemia+and+is+associated+with+other+poor+prognostic+markers"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib41"><span class="bullet">41</span>
                     <span class="author">Longo PG</span>,
<span class="author">Laurenti L</span>,
<span class="author">Gobessi S</span>, et al.
<span class="articleTitle">The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells</span>.
<i>Blood</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">111</span>:
 <span class="pageFirst">846</span>– <span class="pageLast">55</span>.
                     <div class="extra-links" id="e_1_2_6_42_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2007-05-089037" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Cluw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=17928528" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000252458700059" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=846-55&journal=Blood&author=PG+Longo&author=L+Laurenti&author=S+Gobessi&title=The+Akt%2FMcl%E2%80%901+pathway+plays+a+prominent+role+in+mediating+antiapoptotic+signals+downstream+of+the+B%E2%80%90cell+receptor+in+chronic+lymphocytic+leukemia+B+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib42"><span class="bullet">42</span>
                     <span class="author">Nijhawan D</span>,
<span class="author">Fang M</span>,
<span class="author">Traer E</span>, et al.
<span class="articleTitle">Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation</span>.
<i>Genes Dev</i>
                     <span class="pubYear">2003</span>;
 <span class="vol">17</span>:
 <span class="pageFirst">1475</span>– <span class="pageLast">86</span>.
                     <div class="extra-links" id="e_1_2_6_43_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1101%2Fgad.1093903" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFSisrY%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=12783855" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000183682900006" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1475-86&journal=Genes+Dev&author=D+Nijhawan&author=M+Fang&author=E+Traer&title=Elimination+of+Mcl%E2%80%901+is+required+for+the+initiation+of+apoptosis+following+ultraviolet+irradiation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib43"><span class="bullet">43</span>
                     <span class="author">Dong L</span>,
<span class="author">Jiang CC</span>,
<span class="author">Thorne RF</span>, et al.
<span class="articleTitle">Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress</span>.
<i>Oncogene</i>
                     <span class="pubYear">2011</span>;
 <span class="vol">30</span>:
 <span class="pageFirst">3716</span>– <span class="pageLast">26</span>.
                     <div class="extra-links" id="e_1_2_6_44_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fonc.2011.87" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsF2hsL8%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=21423203" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000294244500007" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3716-26&journal=Oncogene&author=L+Dong&author=CC+Jiang&author=RF+Thorne&title=Ets%E2%80%901+mediates+upregulation+of+Mcl%E2%80%901+downstream+of+XBP%E2%80%901+in+human+melanoma+cells+upon+ER+stress"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib44"><span class="bullet">44</span>
                     <span class="author">Smit LA</span>,
<span class="author">Hallaert DY</span>,
<span class="author">Spijker R</span>, et al.
<span class="articleTitle">Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity</span>.
<i>Blood</i>
                     <span class="pubYear">2007</span>;
 <span class="vol">109</span>:
 <span class="pageFirst">1660</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_6_45_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2006-05-021683" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Cgsbc%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=17038534" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000244219400046" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=1660-8&journal=Blood&author=LA+Smit&author=DY+Hallaert&author=R+Spijker&title=Differential+Noxa%2FMcl%E2%80%901+balance+in+peripheral+versus+lymph+node+chronic+lymphocytic+leukemia+cells+correlates+with+survival+capacity"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib45"><span class="bullet">45</span>
                     <span class="author">Fennell DA</span>,
<span class="author">Chacko A</span>,
<span class="author">Mutti L</span>.
<span class="articleTitle">Bcl-2 family regulation by the 20S proteasome inhibitor bortezomib</span>.
<i>Oncogene</i>
                     <span class="pubYear">2008</span>;
 <span class="vol">27</span>:
 <span class="pageFirst">1189</span>– <span class="pageLast">97</span>.
                     <div class="extra-links" id="e_1_2_6_46_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1038%2Fsj.onc.1210744" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXit1yms7c%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=17828309" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000253407000001" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=1189-97&journal=Oncogene&author=DA+Fennell&author=A+Chacko&author=L+Mutti&title=Bcl%E2%80%902+family+regulation+by+the+20S+proteasome+inhibitor+bortezomib"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib46"><span class="bullet">46</span>
                     <span class="author">Baou M</span>,
<span class="author">Kohlhaas SL</span>,
<span class="author">Butterworth M</span>, et al.
<span class="articleTitle">Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells</span>.
<i>Haematologica</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">95</span>:
 <span class="pageFirst">1510</span>– <span class="pageLast">18</span>.
                     <div class="extra-links" id="e_1_2_6_47_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.3324%2Fhaematol.2010.022368" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1Cqtw%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=20378569" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000281933200013" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1510-18&journal=Haematologica&author=M+Baou&author=SL+Kohlhaas&author=M+Butterworth&title=Role+of+NOXA+and+its+ubiquitination+in+proteasome+inhibitor%E2%80%90induced+apoptosis+in+chronic+lymphocytic+leukemia+cells"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib47"><span class="bullet">47</span>
                     <span class="author">Oda E</span>,
<span class="author">Ohki R</span>,
<span class="author">Murasawa H</span>, et al.
<span class="articleTitle">Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis</span>.
<i>Science</i>
                     <span class="pubYear">2000</span>;
 <span class="vol">288</span>:
 <span class="pageFirst">1053</span>– <span class="pageLast">8</span>.
                     <div class="extra-links" id="e_1_2_6_48_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1126%2Fscience.288.5468.1053" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsVSnsbg%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=10807576" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000086988400038" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=1053-8&journal=Science&author=E+Oda&author=R+Ohki&author=H+Murasawa&title=Noxa%2C+a+BH3%E2%80%90only+member+of+the+Bcl%E2%80%902+family+and+candidate+mediator+of+p53%E2%80%90induced+apoptosis"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib48"><span class="bullet">48</span>
                     <span class="author">Vousden KH</span>,
<span class="author">Prives C</span>.
<span class="articleTitle">P53 and prognosis: new insights and further complexity</span>.
<i>Cell</i>
                     <span class="pubYear">2005</span>;
 <span class="vol">120</span>:
 <span class="pageFirst">7</span>- <span class="pageLast">10</span>.
                     <div class="extra-links" id="e_1_2_6_49_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1016%2FS0092-8674%2804%2901252-8" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1Chsg%253D%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=15652475" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000226365400004" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=7-10&journal=Cell&author=KH+Vousden&author=C+Prives&title=P53+and+prognosis%3A+new+insights+and+further+complexity"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib49"><span class="bullet">49</span>
                     <span class="author">Wu G</span>,
<span class="author">Lyapina S</span>,
<span class="author">Das I</span>, et al.
<span class="articleTitle">SEL-10 is an inhibitor of Notch signaling that targets Notch for ubiquitin-mediated protein degradation</span>.
<i>Mol Cell Biol</i>
                     <span class="pubYear">2001</span>;
 <span class="vol">21</span>:
 <span class="pageFirst">7403</span>– <span class="pageLast">15</span>.
                     <div class="extra-links" id="e_1_2_6_50_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1128%2FMCB.21.21.7403-7415.2001" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1WjtLg%253D" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=11585921" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000171486900026" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=7403-15&journal=Mol+Cell+Biol&author=G+Wu&author=S+Lyapina&author=I+Das&title=SEL%E2%80%9010+is+an+inhibitor+of+Notch+signaling+that+targets+Notch+for+ubiquitin%E2%80%90mediated+protein+degradation"target="_blank">Google Scholar</a></span></div>
                  </li>
                  
                  <li data-bib-id="bib50"><span class="bullet">50</span>
                     <span class="author">Kamstrup MR</span>,
<span class="author">Gjerdrum LM</span>,
<span class="author">Biskup E</span>, et al.
<span class="articleTitle">Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma</span>.
<i>Blood</i>
                     <span class="pubYear">2010</span>;
 <span class="vol">116</span>:
 <span class="pageFirst">2504</span>– <span class="pageLast">12</span>.
                     <div class="extra-links" id="e_1_2_6_51_2"><span><a href="/servlet/linkout?suffix=null&amp;dbid=16&amp;doi=10.1002%2Fijc.27863&amp;key=10.1182%2Fblood-2009-12-260216" onclick="newWindow(this.href);return false" class="visitable">Crossref</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=32&amp;doi=10.1002%2Fijc.27863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyqt7bO" onclick="newWindow(this.href);return false" class="visitable">CAS</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=8&amp;doi=10.1002%2Fijc.27863&amp;key=20538790" onclick="newWindow(this.href);return false" class="visitable">PubMed</a></span><span><a href="/servlet/linkout?suffix=null&amp;dbid=128&amp;doi=10.1002%2Fijc.27863&amp;key=000282645900018" onclick="newWindow(this.href);return false" class="visitable">Web of Science®</a></span><span><a class="google-scholar visitable" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=2504-12&journal=Blood&author=MR+Kamstrup&author=LM+Gjerdrum&author=E+Biskup&title=Notch1+as+a+potential+therapeutic+target+in+cutaneous+T%E2%80%90cell+lymphoma"target="_blank">Google Scholar</a></span></div>
                  </li>
                  </ul>
            </div>
         </div>
      </section>
   </section>
   <div style="display:none">
      <ul class="custom-style-list noteList"></ul>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="citedBy-dropzone"><section id="cited-by" class="article-section article-section__citedBy cited-by"><div class="accordion article-accordion"><h2><div tabindex="0" role="button" aria-controls="cited-by__content" aria-expanded="false" class="accordion__control"><span id="citedby-section" class="section__title">Citing Literature</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></h2><div id="cited-by__content" data-source="/pb/widgets/citedBy?page=0&amp;widgetId=f6d59956-1f70-4e88-8811-a42ff3d9d1fa&amp;pbContext=%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fijc.27863%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3Bjournal%3Ajournal%3A10970215%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fijc.v132.8%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3BrequestedJournal%3Ajournal%3A10970215" class="accordion__content cited-by__content"><div class="sciteMetricsDropzone"></div></div></div></section></div>
   </article></div></div><div class="col-lg-4 col-md-4 col-sm-4 hidden-xs hidden-sm hidden-md article-row-right"><div class="publication-cover-info clearfix">



        
        <div class="cover-image-wrapper cover-image__image hasDetails"><a href="/toc/10970215/2013/132/8" title="View Volume 132, Issue 8"><img src="/cms/asset/68a073ac-2ec3-41dd-8f7c-f789287dec78/ijc.v132.8.cover.gif" alt=""/></a></div><div class="extra-info-wrapper cover-image__details"><p class="volume-issue"><a href="/toc/10970215/2013/132/8" title="View Volume 132, Issue 8"><span>Volume</span><span class="val">132</span>, <span>Issue</span><span class="val">8</span></a></p><p>15 April 2013</p><p class="page-range"><span>Pages</span><span> 1940-1953</span></p>



        
        
</div>
</div>



        
        <div>



        
        



        <div class="pb-ad">
            <div id="advert-rail-1" class="advert advert-rail">
			<script>

				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-rail-1' );
				});

			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1011&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27863&pubId=57778996&placeholderId=1014&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
				</a>
			</noscript>
		</div>
        </div>
    





        
        



        <div class="pb-ad">
            <aside>
	<div id="advert-rail-2" class="advert advert-rail">
		<script>

			googletag.cmd.push 		( function () {
				googletag.display 	( 'advert-rail-2' );
			});

		</script>

		<!-- No JavaScript support is a call to an image -->
		<noscript>
			<a href="/action/clickThrough?id=1012&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fijc.27863&pubId=57778996&placeholderId=1013&productId=101018" target="_blank">
				<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
			</a>
		</noscript>
	</div>
</aside>
        </div>
    

</div>
<div class="tabs__wrapper"><div data-default-tab="related" class="tab tab--slide tab--flex sticko__md tabs--xs dynamic-sticko article__tab  tab--flex  tabs--xs "><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list"><li role="presentation" class="tab__nav__item"><a id="pane-pcw-figurescon" href="#pane-pcw-figures" data-slide-clone="self" aria-controls="#pane-pcw-figures" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-figures" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn figures-tab"><i aria-hidden="true" class="icon-multi-figure"></i><h2>Figures</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-referencescon" href="#pane-pcw-references" data-slide-clone="self" aria-controls="#pane-pcw-references" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-references" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn references-tab"><i aria-hidden="true" class="icon-chain"></i><h2>References</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-relatedcon" href="#pane-pcw-related" data-slide-clone="self" aria-controls="#pane-pcw-related" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-related" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn related-tab"><i aria-hidden="true" class="icon-related-circles-extend-button"></i><h2>Related</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-detailscon" href="#pane-pcw-details" data-slide-clone="self" aria-controls="#pane-pcw-details" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-details" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn details-tab"><i aria-hidden="true" class="icon-Icon_Information"></i><h2>Information</h2></a></li></ul><div role="presentation" class="tab__content"><div id="pane-pcw-figures" aria-labelledby="pane-pcw-figurescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-references" aria-labelledby="pane-pcw-referencescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-related" aria-labelledby="pane-pcw-relatedcon" role="tabpanel" class="tab__pane article-row-right__panes"></div><div id="pane-pcw-details" aria-labelledby="pane-pcw-detailscon" role="tabpanel" class="tab__pane article-row-right__panes empty"><div class="contentTab"></div></div><div class="tab__spinner"><div class="tab__spinner--box"><img src="/ux3/releasedAssets/images/spinner.gif" id="spinner" alt=""/></div></div></div></div></div><div class="articleAdvert fixed-element"></div></div></div></article><script>var articleRef = document.querySelector('.article__body:not(.show-references) .article__references');
if (articleRef) { articleRef.style.display = "none"; }

</script><div id="figure-viewer" data-ux3-wrapper="figure-viewer" data-ux3-transformed-by="figureInit" data-ux3-role="parent" role="dialog" class="figure-viewer"><div class="figure-viewer__reg__top clearfix"><div class="figure-viewer__top__right"><a href="#" data-ux3-role="controller" role="button" class="figure-viewer__ctrl__close"><span class="icon-close_thin"><span class="sr-only">Close Figure Viewer</span></span></a></div><div class="figure-viewer__top__left"><a href="#" role="button" class="figure-viewer__ctrl__return is-hidden"><span class="icon-arrow-left"><span class="sr-only">Return to Figure</span></span></a><button title="zoom out" class="figure-viewer__label__zoom icon-zoom-out zoom-out"></button><span tabindex="1" class="zoomSlider js__zoom-slider ui-slider"><input type="range" class="zoom-range"/></span><button title="zoom in" class="figure-viewer__label__zoom icon-zoom-in zoom-in"></button></div></div><div class="figure-viewer__reg__center"><div class="figure-viewer__cent__left"><div class="figure-viewer__hold__fig"><figure class="holder"></figure></div><a href="#" role="button" class="figure-viewer__ctrl__prev"><span class="icon-arrow_l"><span class="sr-only">Previous Figure</span></span></a><a href="#" role="button" class="figure-viewer__ctrl__next"><span class="icon-arrow_r"><span class="sr-only">Next Figure</span></span></a><div class="figure-viewer__hold__list clearfix container"></div></div><div class="figure-viewer__cent__right"><div class="figure-viewer__title"><a title="Open/Close Caption" href="#" class="figure-viewer__ctrl__caption"><span class="icon-doublearrow"></span><span class="figure-viewer__caption__label">Caption</span></a><span class="figure-viewer__title__text"></span></div><div class="figure-viewer__hold__figcap"></div></div></div></div>




        
        <div style="text-align: right!important;"><a style="font-weight: 300!important; font-size: 90%;" href="/doi/pdf/10.1002/ijc.27863">Download PDF</a></div>
</div>
</div></div></div>

        </section>
    
        </div>
    </div><!--end pagefulltext-->
</main>

        </div>
    










        <div data-widget-def="pageFooter" data-widget-id="053994f3-7d80-4bb1-97a4-c67fbc4768cd" class="pageFooter">
        



        
        <footer class="page-footer">
    <div data-pb-dropzone="main">
    



        
        <div class="main-footer">



        
        <style>
    .footer-links {
        text-align: center;
    }
    .footer-links h3 {
        font-weight: 300;
    }
    .footer-links a {
        font-weight: 600;
    }
    @media (min-width: 992px) {
        .footer-links {
            text-align: left;
        }
    }
</style>










        <div data-widget-def="ux3-layout-widget" data-widget-id="2753bec1-a79d-4403-827b-6c788ddd6db3" class="footer-sections">
        



        
            <h2 class="sr-only">
                Additional links
            </h2>
        
        <div class="container"><div class="row"><div class=" col-md-3">



        
        <div class="footer-links mb-3">
  <h3>About Wiley Online Library</h3>
  <ul class="rlist">
    <li><a href="https://www.wiley.com/privacy">Privacy Policy</a></li>
    <li><a href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms of Use</a></li>
    <li><a href="https://onlinelibrary.wiley.com/cookies">Cookies</a></li>
    <li><a href="https://onlinelibrary.wiley.com/accessibility">Accessibility</a></li>
        <li><a href="https://onlinelibrary.wiley.com/publishing-policies">Publishing Policies</a></li>
  </ul>
</div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Help & Support</h3>
    <ul class="rlist">
      <li><a href="https://hub.wiley.com/community/support/onlinelibrary">Contact Us</a></li>
      <li><a href="https://www.wiley.com/customer-success/wiley-online-library-training-hub">Training and Support</a></li>
    <li><a href="https://onlinelibrary.wiley.com/dmca-notification-policy">DMCA &amp; Reporting Piracy</a></li>
 
    </ul>
  </div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Opportunities</h3>
    <ul class="rlist">
      <li><a href="https://onlinelibrary.wiley.com/agents">Subscription Agents</a></li>
      <li><a href="https://onlinelibrary.wiley.com/advertisers">Advertisers & Corporate Partners</a></li>
    </ul>
  </div>
</div><div class=" col-md-3">



        
        <div class="footer-links mb-3">
    <h3>Connect with Wiley</h3>
    <ul class="rlist">
      <li><a href="https://www.wiley.com/network">The Wiley Network</a></li>
      <li><a href="https://newsroom.wiley.com/">Wiley Press Room</a></li>
    </ul>
  </div>
</div></div></div>

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="86584e25-e4db-4118-9550-9b4f5341a4ac" class="copyright-container">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="bfbf6c5d-a650-4662-828f-5275fada9120" class="copyright">
        



        
        <div class="copyright pull-left">Copyright &copy; 1999-2022 <a href="https://www.wiley.com">John Wiley &amp; Sons, Inc</a>. All rights reserved</div>

        </div>
    




        
        <div class="footer-logo pull-right">
        
<a href="https://www.wiley.com" title="Wiley Home Page" aria-label="Wiley"><img alt="Wiley Home Page" src="/pb-assets/tmp-images/footer-logo-wiley-1510029248417.png"></a>

</div>
</div></div></div>

        </div>
    
</div>
    </div>
</footer>

        </div>
    




        
        <!--  -->  <div id="iucr-failure"> <p><i class="icon-notice"></i>The full text of this article hosted at iucr.org is unavailable due to technical difficulties.<a href="#" class="close-iucr-failure"><i class="icon-x"></i></a> </p> </div> 




        
        


















<div class="popup login-popup hidden" role="dialog" tabindex="-1" aria-labelledby="loginPopupHead">



    <div class="content">
        <a href="#" role="button" aria-label="Cancel Login" class="close">
            <i class="icon-tools_close" aria-hidden="true"></i>
        </a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>
        </div>

        <div class="modal__body">
            <div class="ssoLogin">
                
            </div>

            <h2 id="loginPopupHead">Log in to Wiley Online Library</h2>

            































<div class="login-form">
    

    

    
    <form action="/action/doLogin?societyURLCode=" class="bordered" method="post"><input type="hidden" name="id" value="67065c09-4a88-49cd-934c-ac707951d35c" />
        
            <input type="hidden" name="popup" value="true" />
        
        

        
        <input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27863" />
        
            





        <input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27863" />
    

<input type="hidden" name="loginUri" value="/doi/10.1002/ijc.27863" />
            
        
        
        
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="username">Email or Customer ID</label>
                
        </div>
        
        
                <input id="username" class="login" type="text" name="login" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        
                    
                        <div class="actions">
                            
                        </div>
                    
                
    </div>


                
                



















    
    <div class="input-group">
        <div class="label">
            <label for="password">Password</label>
        </div>
        
        
                <input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        <span class="password-eye-icon icon-eye hidden"></span>
        
                
    </div>

                
                    
                        <div class="actions">
                            
                            <a href="/action/requestResetPassword" class="link show-request-reset-password">
                                Forgot password?
                            </a>
                        </div>
                    
                
            
        
        <div class="loginExtraBeans-dropZone" data-pb-dropzone="loginExtraBeans">
            
        </div>

        
                <div class="align-end">
                    
                    
                            
                            <span class="submit ">
                                <input class="button btn submit primary no-margin-bottom accessSubmit" type="submit" name="submitButton" value="Log In" />
                            </span>
                        
                </div></form>
    <div class="societySpecificInstructions">
        
    </div>
</div>

            
                <div class="login-container clearfix form-btn">
                    <a href="/action/registration" class="linkBtn float-left">
                        
                        NEW USER <span aria-hidden="true">></span>
                    </a>
                    
                        <a href="/action/ssostart?redirectUri=%2Fdoi%2F10.1002%2Fijc.27863" class="linkBtn float-right instituation-login">
                            
                            INSTITUTIONAL LOGIN <span aria-hidden="true">></span>
                        </a>
                    
                </div>
            

        </div>
    </div>
</div>




        
        






<div class="popup change-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="changePasswordPopupHead">
    <div class="content">
        <a href="#" class="close cancel" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="changePasswordPopupHead">Change Password</h2>
        </div>
        <div class="modal__body">

            <div class="form">

                <form action="/action/changePassword" method="post"><div class="message error"></div>
                    <input type="hidden" name="submit" value="submit" />
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-old">Old Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-old" class="old" type="password" name="old" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                    </div>
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-new">New Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                        
                            







    


    


    


<div class="password-strength-indicator" data-min="10" data-max="32" data-strength="3">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
                        
                    </div>
                    <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
                <a href="#" class="fakeFormLastElement"></a>
            </div>
            <div class="success-template hidden">
                <h2>Password Changed Successfully</h2>
                <p>Your password has been changed</p>
            </div>
        </div>
    </div>
</div>





        
        





<div class="popup registration-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="createAccountPopupHead">



    <div class="content">
        <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-tools_close"></i></a>
        <div class="modal__header">
            <div class="logoDropZone" data-pb-dropzone="logoDropZone">
                
            </div>

            <h2 id="createAccountPopupHead">Create a new account</h2>
        </div>

        <div class="modal__body">
            <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1002/ijc.27863" />
                <div class="input-group">
                    <div class="label">
                        <label for="4e647394-f751-4441-baa4-df426bca4b6e.email">Email or Customer ID</label>
                    </div>
                    <input id="4e647394-f751-4441-baa4-df426bca4b6e.email" class="email" type="text" name="email" value="" size="15" />
                </div>
                <div class="submit">
                    <input class="button submit primary" type="submit" value="Register" />
                </div></form>
            <div class="center">
                <a href="/action/showLogin" class="show-login">
                    
                    Returning user
                </a>
            </div>
        </div>
    </div>
</div>




        
        



<div class="popup top-drawer request-reset-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="resetPasswordPopupHead">
    <div class="content">
        <div class="modal__header">
            <a href="#" class="cancel close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>

            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="resetPasswordPopupHead">Forgot your password?</h2>
            <p class="sub">Enter your email address below. </p>

        </div>

        <div class="modal__body">

            









<div class="error"></div>


<form action="/action/requestResetPassword" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true" />
    
            <div class="input-group">
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                    <label for="email">Email or Customer ID</label>
                
        </div>
        
        
                <input id="email" class="email" type="text" name="email" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off" />
            
        
    </div>

            </div>
        


    
            <div class="password-recaptcha-ajax"></div>
        

    <div class="message error"></div>

    <div class="form-btn">
        <input class="button btn primary submit" type="submit" name="submit" value="RESET PASSWORD" disabled="disabled" />
    </div></form>
            

            <div class="success-template hidden">

                <p>Please check your email for instructions on resetting your password.
                    If you do not receive an email within 10 minutes, your email address may not be registered,
                    and you may need to create a new Wiley Online Library account.</p>

            </div>
        </div>
    </div>
</div>





        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>




        
        




<div class="popup top-drawer request-username-drawer username-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="requestUsernamePopupHead">
    <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
    <div class="content">
        <h2 id="requestUsernamePopupHead">Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername" />
                <div class="input-group">
                    <div class="label">
                        <label for="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email">Email or Customer ID</label>
                    </div>
                    <input id="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email" class="email" type="text" name="email" value="" size="15" />
                </div>

                <div class="username-recaptcha-ajax">
                </div>

                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" />
                <div class="center">
                    <a href="#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>




        
        <!-- Belongs at the bottom of the page -->

<script type="text/javascript">
if(window._satellite) { 
_satellite.pageBottom(); 
}
</script>
        </div>
    </div>








<script src="/products/acropolis/pericles/releasedAssets/js/build.lazyload.bundle-5a18e39b1102801a673f.js"></script><script src="/products/acropolis/pericles/releasedAssets/js/main.bundle-5d90fdc14b265e545d95.js"></script>
<script type="text/javascript" src="/wro/l0m7~product.js"></script>

<script>var _prum=[['id','59e8fecb3847311aab7b23c6'],['mark','firstbyte',(new Date()).getTime()]];(function(){var s=document.getElementsByTagName('script')[0],p=document.createElement('script');p.async='async';p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();</script>
















<script>
    $(document).ready(function () {
        var start = new Date();
        var doi = $("meta[name='dc.identifier']").attr('content');
        $(window).unload(function () {
            var end = new Date();
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'Duration': end - start,
                    'DOI': doi,
                    'EventType': 'FullTextDuration'
                },
                async: false
            });
        });

        window.onafterprint = function () {
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'DOI': doi,
                    'EventType': 'FullTextPrint'
                }
            });
        };
    });
</script>
<script type="text/javascript">(function(){window['__CF$cv$params']={r:'6e7ad7bd68f87e4c',m:'_.L_rqWcIBsSGnyoD2f.aLXZEug1dRM_fYNrxdBKNnE-1646567101-0-AWALzLPw3WpXfN/z90VKvjCrJI/ZcyaiEG2fX5YmtZ0DrcEd7XgidJpPtfsi5AoAGgOVlw1mhughrnKyxYgiPw7qgHqMb6k16ThonTJIFpIEPO6aDFCb7iSwilv1yt8McLTfRmI2Ht7UI8XLlp01r08=',s:[0x894a6ef64c,0x59b4de2fc5],}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon='{"rayId":"6e7ad7bd68f87e4c","token":"f3dd54df2ac243bab2129483f57546d1","version":"2021.12.0","si":100}' crossorigin="anonymous"></script>
</body>
</html>
